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CHAPTER I 
INTRODUCTION: 
 
An adequate supply of iron is essential for good health. Iron is required for many 
enzymes that are critical for cellular metabolism, and plays a fundamental role in 
oxygen carrying proteins such as hemoglobin and myoglobin. Iron also facilitates 
oxygen use and storage in muscle, interacts with cytochromes in cellular metabolism, 
and serves as cofactor for several tissue enzymes (Yip et al. 1998). Iron can also be 
toxic if present in excess as it is able to catalyze the formation of reactive oxygen 
species. Because of this dual nature, iron must be kept within defined limits and there 
are precise mechanism governing the regulation of the iron homeostasis.  
 
Iron is present in the diet as one of the two forms:  as inorganic (non-heme) iron or 
heme iron. Of these, inorganic iron is the predominant form of iron in dietary 
components of plant origin and accounts for 80-90% dietary iron (Hallberg, 1981; 
Carpenter and Mahoney 1992), with the remaining 10% as heme iron. The inorganic 
form of iron is poorly absorbed in the body because of its low solubility and hence it 
is desirable to make inorganic iron more potentially bioavailable (Berner and Miller, 
1985). Extensive research has been done in last five decades to determine the 
components which can make the dietary iron more potentially bioavailable. A number 
of such identified carriers are ascorbic acid, amino acids and peptides. 
 
Researchers have focused on several dietary components for their iron enhancing or 
inhibiting effect. Many plant components such as phytate, polyphenols (Gilloly et al. 
1983) and soy protein (Cook et al. 1981) inhibit, whereas some animal tissues (Cook 
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et al. 1975, Hurrel et al. 1988) enhance non-heme iron absorption in humans. The 
enhancing effect of meat is attributed to unknown factors, usually referred as ‘meat 
factor’. Meat tissue may also maintain the iron in soluble form, thereby increasing its 
bioavailability (Carpenter and Mahoney, 1992). Not all the animal proteins have 
enhancing effect on iron bioavailability. For example, beef, lamb, liver, pork, poultry 
and fish enhance non-heme iron absorption, but egg, cheese and milk do not (Layrisse 
et al. 1969; Cook et al. 1976; Rasmussen and Hallberg 1979). 
 
However, not much attention has been given to what extent food preparation, such as 
cooking, affects the non-heme iron bioavailability. Cysteine containing peptides of 
meat, e.g. glutathione (Taylor et al. 1986) and sulfhydryl (-SH) and (disulphide 
groups) in meat (Hoffman and Hamm 1978), have been suggested to be responsible 
for ‘meat factor’, but the effect of cooking on these factors has not been given much 
consideration even though it is well known that sulfhydryls are heat labile (Taylor et 
al 1986). Baech et al. studied the effect of increasing cooking temperature on meat 
and concluded that increasing cooking temperature does not affect the non-heme iron 
absorption from a phytate rich meal (Baech et al. 2002). But the reference point in this 
study was meat cooked at 70oC and not raw meat and also the meal was phytate rich.  
 
Based on the literature review the objective of the present study is to investigate the 
effect of increasing cooking temperature of chicken muscle on in-vitro measure of 
non-heme iron bioavailability. The specific objectives are 
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 To study the effect of cooking temperature on production of potentially 
bioavailable iron species resulting from in-vitro pepsin and pancreatin 
digestion. 
 To study the effect of cooking temperature on critical amino acids, such as, 
sulfhydryl and histidine content of chicken muscle. 
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CHAPTER II 
LITERATURE REVIEW: 
II.A Iron: 
 
Iron is placed in 8th group and 4th period in periodic table and has atomic weight of 
55.845. Iron is a relatively abundant element on earth and is the fourth most common 
metal on earth. Iron catalyzes great number of biochemical reactions, many of which 
are related to the chemical nature of the element characterized by two principle 
oxidation states: divalent iron (Fe II (d-6)) and trivalent (Fe III (d-5)) and their 
associated ability to form complexes.  
 
II.B The history of Iron: 
 
The relation of iron to blood formation did not become apparent until the seventh 
century when two English physicians, Sydenham and Willis, found simple salts of 
iron to be of value in treatment of chlorosis in women. This relationship was placed 
on more rational basis by the discovery that iron is a characteristic constituent of 
blood. After this Lecanu had shown that hemoglobin contains iron, and, in 1886, 
Zinoffsky had estimated the iron content of horse hemoglobin to be 0.335%. In 1937, 
McCance and Widdowson came up with new concept that the amount of iron in the 
body must be regulated by controlled absorption. (Underwood, 1971). 
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II.C Iron in Body Tissue and Fluids: 
 
The total iron content of the animal body varies with species, age, sex, nutrition, and 
the state of health. Normal adult man is estimated to contain 4-5g of iron or 60-70ppm 
of whole body of a 70 kg individual (Lamb et al. 1958). Most of the body iron is 
present in complex form bound to proteins, either as porphyrin or heme compounds, 
particularly hemoglobin and myoglobin, or as non-heme protein-bound compound 
such as ferritin and transferrin. The hemoprotein and flavoprotein enzymes together 
constitute less than 1% of total body iron. Free, inorganic iron is present in negligible 
quantities (Lamb et al. 1958).  
Among the organs and tissues of the body, the liver and spleen usually carry highest 
iron concentration, followed by kidney, heart, skeletal muscles, pancreas, and brain 
(Underwood, 1971). 
 
II.D Dietary Sources of Iron:  
 
The overall intake of iron from different diets varies greatly with the proportion of 
iron-rich and iron-poor foods that they contain, with the degree of contamination with 
iron to which they have been exposed, and, to some extent, with the locality from 
which they are obtained. Average U.S. diet was reported to supply 12-15 mg iron per 
day value, Australian diet, which is typically high in meat, have been estimated to 
supply 14-20 mg iron. A typical poor Indian diet was shown to provide only 9 mg 
iron, whereas improved diet containing less milled rice and more pulses and green 
vegetables could provide as much as 60 mg iron/day (Underwood, 1971). 
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The dietary source of iron influences the efficiency of iron absorption, which ranges 
from <1% to >20% (Underwood, 1971). Non-heme iron in food of vegetable origin is 
at lower end of the range, dairy products are in the middle, and meat is at the upper 
end. About 10% of the small amounts of iron in unfortified formulas or whole milk is 
absorbed. The iron content of the breast milk is same as that of cow’s milk, but about 
50% of the iron in the breast milk is absorbed, hence breast milk is better sources of 
iron than cow’s milk and unfortified formulas (Ziegler and Filer, Jr. 1996). Its better 
absorption efficiency does not entirely make up for its low iron content, and after age 
of 6 months breast-fed infants require an additional sources of iron to meet their iron 
requirement (Ziegler and Filer, Jr. 1996) 
Meat is good source of iron because much of it is in the form of heme-iron, which is 
absorbed 2-3 times more than non-heme iron completely than non-heme iron (Ziegler 
and Filer, Jr. 1996). In addition, it has been reported that factors in the meat promote 
non-heme iron absorption from the entire meal (Ziegler and Filer, Jr. 1996). 
 
II.E Iron Chemistry and Biochemistry: 
 
The study for mechanism of iron absorption has been controversial, probably due to 
the complex chemistry of the element and to the different capabilities of that 
biological membrane have for iron uptake. Iron catalyzes great number of chemical 
reaction and many of these reactions are related to the chemical nature of the element 
which is characterized by two principle oxidation states: divalent iron (Fe II (d-6)) and 
trivalent iron (Fe III (d-5)) and their associated ability to form complexes.  
In water and in absence of oxygen, iron is present in the hexa-aqua complex divalent 
ion, which is readily oxidized upon increasing oxygen concentration to trivalent aqua 
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complex of similar structure according to the one electron reversible reaction shown 
below and oxygen become a source of free radicals: 
 
Fe (II)
 aq + O2                               Fe (III) aq + O2-. 
 
The water solubility of trivalent hexa aqua-complex is function of pH and rapidly 
decreased by increasing pH value from 1 to 9. Due to the complex hydroxylation 
reactions of deprotonation of the aqua-complex, oxo-hydroxy species of decreasing 
solubility are formed in water as shown in fig. below (Cremones P et al. 2002): 
 
   
  
Fig. II.E.1. Hydrolytic reaction of iron as function of pH. At low pH values iron is 
present in solution as free ion. Aqua complex oligomers are generated at pH values 
higher than 2 and polymerization occurs by further increasing the pH; x is the 
estimation of number of iron atoms present in the aquated form, y and z are the O- and 
the (OH)- in the bridging position of the polynuclear core bonded to x by the 
relationship 2y-z/p=n. Precipitation of these forms occurs at the x values higher than 
20 (Cremones P et al. 2002).  
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In biological media at low oxygen tension, Fe(OH2)62+ is the predominant species, 
while Fe(OH2)63+ is minor species due to its low solubility (10-12mol/l at pH 7) 
(Flynn, 1984; Cornell et al. 1989).  
These chemical characteristics are suggestive, in principle that iron II derivative can 
be taken up more easily than iron III derivative by cell membrane as a consequences 
of more favorable solubility properties.  
 
Iron balance and distribution:  
 
 
Fig. II.E.2. Iron balance in man.  
In normal conditions the mammals are able to maintain iron homeostasis by 
controlling absorption from the diet and avoiding the overload (Fig 2). Appropriate 
amounts of iron (10-15mg) in the diet are taken up in the intestinal mucosa (normally 
1 mg/day) and transported by plasma ferritin to the utilization compartment (mainly 
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red blood cells) and the storage protein (ferritin) from which it can be mobilized when 
required. Iron can be recycled within mammalian cells and any uncontrolled losses 
from epithetical cells or via blood loss is balanced by the amount of absorbed iron. 
The daily body turnover in healthy human is 1 mg and can reach 4-5 mg in 
menstruating woman. Figure II summarizes the iron balance in man (Cremones et al. 
2002): 
 
II.F Iron Absorption:  
 
II.F.1 Introduction: 
 
Iron absorption normally occurs in the duodenum and upper part of jejunum. The 
availability of ingested iron for absorption and the amount absorbed depends upon the 
chemical nature and quantity of iron the diet, the presence of other factors in ingested 
foods, the effect of gastrointestinal secretion and the absorptive capacity of the 
intestinal mucosa. The absorptive capacity is regulated by two internal factors, the 
size of the iron stores and the rate of erythropoiesis (Bothwell et al. 1979).  
 
Iron absorption has been assumed to have an important role in regulation of iron 
balance. Iron balance in the normal adult male is limited with an exchange of ~1 
mg/day. Absorption from the test meal is high if iron stores are depleted and is 
surpassed if iron stores are enlarged (Burke et al. 2001). 
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II.F.2 Mechanism of Iron Absorption: 
 
Dietary iron compounds are divided into two types, heme and non-heme iron. In 
humans heme iron is absorbed more efficiently than non heme iron. Hence heme iron 
may contribute a large amount of absorbed iron even though it represents a lesser 
fraction of ingested iron. Heme and non-heme iron is absorbed in the body by 
different mechanisms, which are described below. 
 
 
II.F.3 Non-heme Iron absorption: 
 
Non-heme (inorganic) iron is present in the diet as either reduced ferrous (Fe II) or 
oxidized ferric (Fe III) form. Under normal physiological condition (i.e. neutral pH 
and in presence of oxygen) ferrous iron is rapidly oxidized to ferric form and 
precipitate as iron hydroxide. In the luminal contents of gut, iron is likely to be in the 
ferric form and therefore poorly potentially bioavailable. Non-heme iron is absorbed 
early in digestion mainly in the duodenum, where the low pH favors solubility. 
Further down the intestine it is likely that the formation of insoluble ferric complex 
reduces bioavailability. The transport of the non-heme iron across the duodenal 
mucosa has been studied intensively over the years and is highly adaptive to change in 
iron status (stores, erythropoiesis, and hypoxia). Much progress has been made in the 
last few years in identifying the proteins involved in this process (Miret et al. 2003).  
 
Non-heme iron is transported into the cell in the ferrous form, mainly by the carrier 
DMT1 (Divalent Metal Transport 1), also known as natural resistance associated 
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macrophage protein (Nramp2). Several steps are involved in non-heme iron 
absorption, viz. 
1. transport to erythrocytes across the brush border membrane 
2. movement of the iron through the cell 
3. transport across basolateral membrane (transfer step) and  
4. passage through the interstitial space and capillary wall.  
Two carriers are required, DMT1 for the uptake step and ferroportin 1/IREG1/MTP1 
for the transfer step. Several other proteins have been shown to be involved in the 
absorptive process, either directly or indirectly. A ferric iron reductase on the brush 
border membrane, Dcytb, is believed to be responsible for the reduction of ferric to 
ferrous form before uptake by DMT1 (Morgan and Oates, 2002). For optimal 
transport of ferrous form, DMT1 also require a proton gradient provided by gastric 
acid to co-transport ferrous iron. The intracellular movement of iron is poorly 
understood but the copper containing ferroxidase, hephaestin (Hp) is involved (Valpe 
et al. 1999). 
 
II.F.4 Heme iron absorption: 
 
Heme iron derived from meat is an important source of iron, and is highly potentially 
bioavailable. 
The absorption of hemoglobin and myoglobin derived iron differs from that of 
inorganic iron. Most heme-iron enters the small intestinal absorptive cells as an intact 
metalloporphyrin. Current evidence is that this is facilitated by heme receptor and 
heme enters the cell via vesicle (Grasbeck et al. 1979). Once heme is within the cell, 
iron is released from porphyrin by mucosal heme oxygenase so that it can enter the 
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circulation as inorganic iron.  Unlike non-heme iron, heme iron is soluble in alkaline 
solutions and is precipitated as hematin in acidic milieu (Conrad et al. 1966). This 
makes the chelation less important to maintain solubility in duodenum. There is 
common intracellular pathway for heme and non-heme iron absorption, demonstrated 
by competitive inhibition between simultaneously and sequentially administered heme 
and non-heme iron (Hallberg and Solvell, 1967).   
 
II.G Regulation of Iron Absorption: 
 
Humans have limited capacity to excrete iron, so the amount or iron in the body is 
controlled at the point of absorption in the proximal small intestine. The iron uptake 
by mucosa cells and iron transfer into the carcass are significantly increased in iron 
deficient animal as compared to iron overloaded animals (Adams et al. 1991). Thus 
the uptake from the mucosa cell appears to be the main site of regulation of non-heme 
iron absorption. Storage iron status is also a well known factor for regulation of iron 
absorption. Enhanced erythropoiesis is another potent stimulus of iron absorption 
(Anderson et al. 2005).  
 
Early autoradiographic studies by Conrad and Crosby showed that the mature 
epithelial cells of mid to upper villus are able to absorb iron from the diet; it is the 
cells of intestinal crypts that are able to take up iron from the body (Conrad and 
Crosby, 1963). The inference from this study is that the crypt cells are the ones that 
respond to the body signals to modulate the intestinal iron absorption.   
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The concentration of iron within the crypt cell is, thus, an important determinant of 
iron absorption. The crypt cell iron concentration must, thus, reflect body iron needs 
and must in turn modulate the expression of gene encoding proteins important for 
vectorial iron transport across the mature enterocyte. The mechanism by which the 
crypt cell’s intracellular iron concentration may respond is poorly understood. 
Anderson studies the distribution and functions of the transferrin receptor in the small 
intestine and have shown that most receptors are located at the basolateral membranes 
of the intestinal crypt cells. These transferrin receptors are able to bind, internalize 
and recycle transferrin to the cell surface and, in short, the crypt cells appear to 
possess fully functional transferrin/transferrin receptor iron delivery system. These 
studies have indicated that the transferring receptor provides one pathway by which 
crypt cell could kept informed about body status, but one can not exclude the 
possibility that the crypt cell could be informed in other ways or by additional signals 
(Anderson, 1996). 
 
The following figure shows the model for control if iron absorption. 
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Figure II.G.1: Model for control of iron absorption. Signal from the body to 
modulated iron absorption are received by epithelial cells of the intestinal crypt. 
These cells are able to respond to the body signals but are unable to take up dietary 
iron themselves. The body signals, perhaps by altering the intracellular iron status of 
the crypt cells, determine the expression of the genes important for the absorption 
process. The proteins encodes by these genes are expressed as functional membrane 
transporters after the epithelial cells have migrated up the villus and matured into 
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absorptive enterocytes. These cells are now able to transport dietary iron to the 
circulation but appear to have little capacity to receive iron from the body (Anderson, 
1996). 
 
II.H The concept of Iron Bioavailability: 
 
Iron bioavailability can be defined as the proportion of total mineral or total trace 
element in food, meal, or diet, which is utilized for normal physiological body 
functions. Various methods have been used to study the dietary bioavailability of iron 
in man. The chemical balance technique is the only method that directly measures the 
dietary iron absorption. That method, however, is insensitive, imprecise and time 
consuming, and it gives no information about the iron absorption from different 
meals.  
 
The introduction of radioisotopes made it possible to label single food items 
biosynthetically with radioiron.  Studies with labeled foods have shown that 
absorption from individual food differs markedly. These differences in the 
bioavailability are apparently related to differences in solubility, dissociation and 
uptake of chemically uncharacterized iron compounds in foods. 
 
In recent years some unexpected observations have provided the important 
breakthrough and led to the development of extrinsic tag method. When single food 
biosynthetically labeled with radioiron (intrinsic tracer) was carefully mixed with a 
trace amount of iron salt labeled with another radioiron isotope (extrinsic tracer), the 
observations was made that the absorption of two tracers, from such doubly labeled 
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foods, was almost identical. The magnitude of absorption was different from different 
foods and in different subjects, but the absorption from the extrinsic and intrinsic 
tracers was the same in each subject. Based on these finding the concept of common 
non-heme iron was introduced. This concept assumes that the non-heme iron 
compound in different foods in a meal can be uniformly labeled by extrinsic inorganic 
radioiron tracer (Hallberg, 1981). Heme iron cannot be labeled by extrinsic inorganic 
tracer. 
 
II.I Methods to Determine Iron Bioavailability: 
 
Three methods are universally used for determination of iron bioavailability discussed 
below: 
 
II.I.1. In-vitro Method: 
 
In in-vitro method the sample is subjected to pepsin and pancreatin digestion with a 
dialysis bag of specific MWCO (Kane and Miller, 1984). The dialyzable iron is 
measured after pancreatin digestion and accounted for potentially bioavailable form of 
iron. 
In this method the dialyzable iron is taken as potentially bioavailable form of iron, as 
it is necessary for the iron to get bound to a ligand and cross the dialysis tube 
membrane to get absorbed in human body.  
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II.I.2. Caco-2 Cell Method: 
 
Caco-2 cell line has properties similar to human intestinal cells, which are utilized for 
determination of iron bioavailability. The caco-2 cultured plates are coupled with 
inserts carrying a dialysis membrane of specific MWCO and placed in the digestion 
sample (Swain et al. 2002). Once the digestion is over the uptake of iron by caco-2 
cells is determined and accounted for potentially bioavailable forms of iron.  
In this method the uptake of iron by Caco-2 cell is important as caco-2 cell line 
resembles to human intestinal cell. 
 
II.I.3. In-vivo Method: 
 
In-vivo method refers to the use of living subjects to study iron bioavailability. In case 
of animals, a specific diet, containing a stable isotope of iron called as radio labeled 
iron, is added to meal externally and given to the subjects during the study period. 
After the study period, the animal is sacrificed and hemoglobin concentration and 
plasma iron concentration is estimated.  
 
In case of humans, healthy volunteers are selected randomly and their hemoglobin 
and plasma iron concentration is determined. Then the subjects are given the test meal 
containing radio labeled iron at regular interval. The blood and fecal samples are 
collected at regular intervals and analyzed for radio labeled iron. At the end of the 
study the data is analyzed for difference in blood iron before and after study and iron 
bioavailability is estimated by different available methods like WHO’s method 
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(FAO/WHO 1988), Monsen’s method (Monsen et al. 1978), Tseng’s method (Tseng 
et al. 1997) etc. 
 
II.J. Individual factors affecting non-heme iron bioavailability:  
 
II.J.1. Iron status: 
 
The absorption of non-heme iron is markedly influenced by the iron status of the 
subject – more iron is absorbed by the iron deficient and less by the iron-replete 
subjects. This leads to marked subject to subject variability, which makes it difficult 
to determine whether difference in test meal studied in different group subjects relate 
to properties of the meals or to the iron status of the subject. 
 
The effect of difference in iron status among different subjects can be adjusted by 
obtaining independent measure of their absorptive capacity. This is accomplished by 
determining the absorption from the standard dose of inorganic radioiron given at 
physiological levels under standardized conditions (Hallberg, 1981). 
 
There is good correlation between iron stores and serum ferritin, and it has been 
shown that there is good correlation between serum ferritin and non-heme iron 
absorption (Bezwoda et al. 1979). Therefore serum ferritin can also be used as an 
alternative to the reference dose absorption. However, serum ferritin is only an 
indirect measure of individual’s ability to absorb iron, and extraneous factors such as 
minor infections may affect iron absorption and serum ferritin in opposite direction 
(Hallberg, 1981). 
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II.J.2. Pregnancy: 
 
The bioavailability of dietary iron increases during pregnancy and is roughly parallel 
to the increased iron requirements.  
 
II.J.3. Disease States: 
 
In gastric achlorhydria, the absorption of dietary non-heme iron is reduced in relation 
to the absorption from ferrous iron salt (Rasmussen, 1981). After partial gastrectomy, 
a decrease in bioavailability of non-heme dietary iron is often observed. The 
magnitude of the decrease depends upon the type of the gastric operation performed 
(Magnusson, 1979). In idiopathic hemochromatosis, the absorption of non-heme iron 
marked increases in relation to the size of iron stores (Bezwoda, 1976).  
 
II.K. Dietary factors influencing the bioavailability of non-heme iron: 
 
II.K.1. Ascorbic acid: 
 
It was shown early on that ascorbic acid or orange juice with a high content of 
ascorbic acid markedly increases the food iron absorption. This effect is due to 
promotion of non-heme iron absorption (Apte and Venkatachalam, 1965) and there is 
no effect on absorption of heme iron. The absorption increase is related to the amount 
of ascorbic acid. A significant effect can be observed with only 25 mg of ascorbic 
acid, which is amount present in a third of the glass of orange juice. Orange juice 
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containing 70 mg ascorbic acid increased iron absorption from breakfast meal 2.5 
times (Rossander et al. 1979). 
 
In summary, ascorbic acid is very potent promoter of non-heme iron absorption. 
Crystalline ascorbic acid and native ascorbic acid have about the same promoting 
effect. Cooking and baking can destroy the ascorbic acid and hence its effect on iron 
absorption. The effect of ascorbic acid seems to be independent of the effect of other 
promoters, such as meat. However when two promoters are present the effect of each 
promoter will be smaller as compared to when it is present alone. In the presence of 
inhibitor of non-heme iron, such as tea, the relative enhancing effect of ascorbic acid 
on non-heme iron absorption is same (Hallberg, 1979). 
 
The effect of ascorbic acid may be related both to its reducing effect, preventing the 
formation of insoluble ferric hydroxide, and to its effect on forming soluble 
complexes with ferric iron, which preserve the iron solubility in more alkaline 
duodenal pH (Conrad and Schade, 1968). 
 
In recent study (Engle-Stone et al. 2005) it has been shown that meat and ascorbic 
acid can promote iron availability from iron-phytate but not from iron-tannic acid 
complexes.  
 
II.K.2. Meat and Fish: 
 
An enhancing effect of meat and fish was first time reported by Layrisse et al. in 1968 
and confirmed by many other studies (Taylor et al. 1986; Morrissey, 1998; Seth and 
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Mahoney, 2000; Swain et al. 2002). The absorption-promoting effect of meat is dose 
related (Underwood 1971). The enhancing effect of meat on iron bioavailability is 
termed as ‘meat factor’. Several investors have tried to clarify the mechanism of this 
meat effect. Many components such as amino acids, histidine (Swain et al. 2002), 
histidine residue (Mulvihill and Morrissey, 1998; Seth and Mahoney, 2000), 
carbohydrate fractions (Rozo et al. 1986, Huh et al. 2004), sulfhydryl (Taylor et al. 
1986) etc have been reported to be responsible for enhancing effect on iron 
absorption.  
 
II.K.3. Tannates: 
 
It has been reported that tea markedly reduced the iron absorption of non-heme iron 
absorption from foods. The absorption from bread was reduced to one third and from 
soup to one fourth when served with tea compared with water (Disler et al. I 1975). 
This effect has been attributed to the formation of iron-tannate complex. It has also 
been reported that the tannins may be partly responsible for low bioavailability of iron 
in many vegetable foods (Disler et al. II 1975). Tannates are also present in coffee and 
it is possible that inhibiting effect of coffee is due to tannates.  
 
II.K.4. Phytates, phosphates and fibers:  
 
Several studies have shown that the sodium phytate decreases iron absorption in man 
(Hallberg and Solvell, 1967; McCance et al. 1943). The lower fraction of iron 
absorbed from brown bread compared with white has been attributed to the high 
content of iron phytates in bran (Moore, 1968). Most of the phytate, however, is 
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broken down during leavening and baking of bread, with corresponding increase in 
inositol. The final content of phosphate in wheat is not such of magnitude that it can 
affect the iron absorption with increasing amounts of bran. It has been suggested that 
the inhibiting effect of bran is due to its content of fiber components (Rasmussen, 
1974). Monoferric phytate, prepared from wheat, bran have been reported to have 
higher bioavailability for rats (Morris and Ellis 1976). 
 
II.K.5. Egg and Milk: 
 
Eggs have been reported to decrease the absorption of iron. Egg yolk has been 
reported to decrease the absorption of iron from inorganic salt (Elwood 1968). 
Milk has been found to decrease the iron absorption from meals with low 
bioavailability.  
 
II.K.6. Organic Acids: 
 
Salovara et al. have observed that organic acids show a concentration-dependent 
influence on the uptake of ferrous and ferric iron in Caco-2 cells (Salovara et al. 
2002). Results obtained by Salovara et al. showed a correlation between absorption 
pattern and chemical structure of the acids. Accordingly, four-carbon dicarboxylic 
acids, such as tartaric, malic, succinic, and fumaric acid, showed a positive effect on 
both ferric and ferrous iron absorption in the cells, but to varying degrees. The 
number of hydroxyl groups was shown to be important. Citric, lactic, and oxalic acid 
(2-, 3-, and 5-carbon carboxylic acids) had a similar and very negative effect on 
ferrous iron and a positive effect on ferric iron absorption. Acetic and propionic acid, 
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which are simple 2- or 3-carbon monocarboxylic acids, showed a positive effect on 
ferrous iron and no effect on ferric iron uptake (Salovara et al. 2002). 
 
In a review, oxalate has been reported to decrease in iron bioavailability (Conrad, 
1970).  
 
Succinic acid, which increases the iron absorption from pharmaceutical doses of iron, 
has about the same 35% absorption-promoting effect on dietary non-heme iron in 
standard meal, when given in the amount of 150 mg (Hallberg, 1979). 
 
II.L. The concept of ‘Meat Factor’: 
 
The concept of ‘meat factor’ was established when Layrisse et al. showed that the 
absorption of iron from different vegetable foodstuff was markedly increased when 
they were served with meat and fish (Layrisse et al. 1969). This observation has been 
confirmed by number of studies both in-vitro and in-vivo (Amine and Hegsted, 1971; 
Monsen and Cook 1979; Kane and Miller, 1984; Slatkavitz and Clydesdale, 1988). It 
is evidence that meat and fish promote inorganic iron absorption. However, the 
mechanism by which meat acts to promote absorption of non-heme iron from diet is 
still unknown. Several factors have been proposed to be responsible for meat factor 
and are summarized below. 
 
II.L.1. Sulphydryls: 
 
Hamed et al. suggested that the sulphydryl (-SH) groups of cysteine and glutathione 
are capable of reducing Fe(III) to Fe(II) at low pH (Hamed et al. 1983). Kirwan et al. 
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suggests that –SH rich myofibrillar fractions of meat, in particular, the heavy 
meromyosin fractions may be a component responsible for meat factor (Kirwan et al. 
1993). Mulvihill and Morrissey studied the effect of –SH content of animal proteins 
on production of dialyzable iron and showed that the –SH content of meat plays 
important role in this indicator of iron bioavailability (Mulvihill and Morrissey, 
1998).  
 
Mulvihill et al. showed that heavy meromyosin, which has 25 –SH residue per 
molecule, produces more amount of dialyzable iron than light meromyosin molecule, 
which has 4-5 –SH residue per molecule (Mulvihill et al. 1998).  
 
Taylor et al. studied the effect of cysteine containing peptides released during the 
meat digestion on iron absorption in humans. In this study the sample was divided 
into two batches: in first batch the thiol groups of cysteine residues were preserved 
and in second batch the thiol groups were oxidized to cystine. The extracts were given 
to the subjects in form of a soup. The hemoglobin and serum ferritin concentration of 
the subjects was analyzed. The results obtained from this study suggested that the 
enhancing effect of meat on non-heme iron absorption is due to cysteine containing 
peptides, like glutathione, and not the free amino acids (Taylor et al. 1986).  
 
II.L.2 Histidine: 
 
Seth and Mahoney studied the role of histidine residue in chelation of iron by peptides 
from chicken muscle proteins in-vitro and concluded that histidine residue do 
contribute to iron chelation and could be involved in promotion of iron absorption by 
25 
 
muscle tissue (Seth and Mahoney, 2000). Swain et al. used Caco-2 cells method to 
study influence of beef protein on iron absorption and suggested that the enhancement 
of non-heme iron absorption of beef may be due to peptides produced during 
gastrointestinal digestion and that histidine content may be important factor 
contributing to this effect (Swain et al. 2002).  
 
II.L.3. Protein Digestibility:  
 
The importance of protein digestibility in promoting iron bioavailability has been 
addressed by many investigators (Bothwell et al. 1979; Kane and Miller, 1984; 
Slatkavitz and Clydesdale, 1988). Rasmussen and Hallberg studied the effect of 
animal proteins on the absorption of food iron in man and concluded that absorption-
promoting effect of meat proteins may result from the peptides formed during 
digestion (Rasmussen and Hallberg, 1979). Kane and Miller (Kane and Miller, 1984) 
investigated the effect of selected proteins on iron-bioavailability in-vitro and came 
up with a conclusion that protein and iron interactions occur during the digestion and 
results in iron absorption.  
 
Mulvihill and Morrissey showed that low molecular weight digestion products 
enhance iron bioavailability in-vitro, while large molecular weight products may bind 
iron and hence depress its bioavailability and concluded that the small molecular 
weight protein degradation products may contribute to ‘meat factor’ (Mulvihill and 
Morrissey, 1998). Mulvihill et al. suggested that the myofibrillar protein fraction, in 
part, may be responsible for the enhancing effect of meat on the in-vitro 
bioavailability of non-heme iron (Mulvihill et al. 1998). Kapsokefalou and Miller 
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concluded that the protein digestibility may be an important factor for iron 
bioavailability in-vitro as more completely digested the protein is, more thiol groups 
would be exposed and available for reducing iron (Kapsokefalou and Miller, 1991).  
Conflicting results were obtained by Huh et al., who stated that the protein digestion 
is not necessary for iron bioavailability and carbohydrate fractions, which are 
extracted at low pH, are responsible for iron bioavailability in cooked fish muscle 
(Huh et al. 2004).. 
 
II.L.4. Carbohydrates: 
 
It has been suggested that the absorption of radioiron is markedly influenced by the 
kind of dietary carbohydrate (Amine and Hegsted, 1971). Amine and Hegsted found 
that iron utilization is greatest with diets containing lactose, less in diets containing 
sucrose and least with diets in which carbohydrate supplied was starch. However the 
effect of carbohydrates was not uniform when different iron sources were used 
(Amine and Hegsted, 1975). Rozo et al. studied effect of some carbohydrates on iron 
absorption in rats and found observed that rats fed with high starch meal resulted in 
reduction in iron absorption, whereas glucose, fructose and lactose enhanced iron 
absorption (Rozo et al. 1986). Huh et al. studied the effect of cooked fish on iron 
uptake and found that the acid extract, which contained high amounts of 
carbohydrates and negligible amounts of proteins and amino acids, increased iron 
uptake up to 4.9 fold by Caco-2 cells (Huh et al. 2004). Huh et al. also proposed that 
the carbohydrates responsible for iron uptake may be oligosaccharides from 
glucosaminoglycans which is present in the extracellular matrix of muscle tissue (Huh 
et al. 2004). 
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II.M. Effect of Cooking on ‘Meat Factor’: 
 
The literature review suggests that the effect of cooking on iron bioavailability has not 
been given much emphasis upon. The research by Baech et al. investigated the effect 
of cooking temperature of pork on iron bioavailability. Pork was prepared in the form 
of meat patties and packed into hermetically sealed aluminum cans. These cans were 
divided into three different batches and the cans were exposed to one of the three heat 
treatments as follows: by circulating the water at 70/95oC for 60 mins till the final 
centre temperature reached 69.94oC and maximal heat treatment at 120oC in an 
autoclave. The patties were given along with a phytate rich meal to the test subjects 
and the serum ferritin and hemoglobin concentration was measured at the end of the 
study. The cysteine content of the heated samples dropped by 19%, but the iron 
bioavailability was not affected. The study concluded that the cooking temperature 
does not affect non-heme iron absorption (Baech et al. 2002). But in this study the 
meal was phytate rich, and it is well established that phytate is iron absorption 
inhibitor (Hurrel et al. 1992) and may interfere with the study.  
 
Another study by Huh et al. suggested that carbohydrate fractions from cooked 
lyophilized fish promote iron bioavailability. The HPLC analysis of the extract 
showed that the content of protein and amino acid was negligible and the fraction was 
highly rich in carbohydrates (Huh et al. 2004). But the fish muscle was not heated 
under controlled temperature conditions, which may have destroyed thiol groups 
which are suggested to be responsible for meat factor. This study suggested that 
carbohydrates in chicken may also have some effect of iron bioavailability, and to 
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investigate the effect of carbohydrates on iron bioavailability, if there is any, is also 
one of the aims of this study. 
 
Based on the literature findings, the aim of this work is to investigate the effect of 
heating temperatures on production of potentially bioavailable forms of iron and the 
specific components of chicken, if any, affecting the bioavailability of iron. 
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CHAPTER III 
MATERIALS AND METHODS 
 
III.A. Introduction: 
 
Literature survey clearly mentioned that animal protein has a positive effect on iron 
absorption. But, there is very little evidence for effect of cooking chicken muscle on 
iron absorption. Using a standard model which involves only pepsin and pancreatin 
enzymes and water besides the different cooked samples was thought to be a better in-
vitro model to determine the effect of cooking chicken muscle on iron bioavailability 
as compared to other in-vitro methods available. Production of dialyzable iron was 
determined for preliminary samples of cooked chicken to evaluate the consistency and 
reliability of the methodology.  
 
 
III.B. Chemicals: 
 
All chemicals were of analytical grade. 
 
Water: Distilled-deionized water (DDW) was prepared using a Bantam Demineralizer 
Model BO-5 (Branstead Company, Boston, MA) with an ultrapure cartridge 
(Branstead International, Dubuque, IA, USA). DDW was used throughout the 
experiments. 
Pepsin: Pepsin from porcine stomach mucosa (Sigma Chemical Co. St. Louis, MO, 
USA), P-7012, was prepared by dissolving 100mg in 5 ml of 0.01N HCl. Pepsin was 
added to the protein samples at a pepsin:protein ratio of 1:25 (w/w). 
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Pancreatin: Pancreatin from porcine pancreas (Sigma Chemical Co. St. Louis, MO, 
USA), P-1750, was prepared by suspending 200 mg in 50 ml of 0.1M PIPES/bile, at 
pH 6.5. Pancreatin was added to the protein samples at a pancreatin:protein ratio of 
1:50 (w/w) 
PIPES/Bile: PIPES (Piperazine-N, N’-bis[2-ethanesulfonic acid]) disodium salt 
(Sigma Chemical Co. St. Louis, MO, USA). PIPES, P-3768, was dissolved in DDW 
at a concentration of 0.1M and the final pH was adjusted to 6.5. BILE salts, at the 
concentration of 50mg/ml, were dissolved in 50 ml of this buffer. 
Dialysis tubing (Spectrum Labs Inc. Gardena, CA, USA): Spectra/Pro1 membrane 
tubing with a diameter of 20.4 mm and a MWCO of 6,000 - 8,000 Da was used for 
dialysis. Twenty centimeter length membrane tubes were cut and soaked in 5 mM 
EDTA solution in DDW for at least 2 hrs and rinsed several times with DDW to 
remove all the EDTA prior to use. 
Reducing Protein Precipitant Solution: 100g of crystalline trichloroacetic acid (TCA), 
50g of hydroxylamine • hydrochloride and 100 ml of 12N HCl were brought to 1 L 
with DDW.  
Non-reducing Protein Precipitant Solution: 100g of TCA and 100 ml of 12N HCl 
were brought to 1 L with DDW.  
Ferrozine Reagent: 3-(2-pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4-triazine 
monosodium salt. (Sigma Chemical Co. St. Louis, MO, USA P-9762). Ferrozine was 
dissolved in DDW to prepare a 9 mM solution. 
Ammonium Acetate Buffer: Ammonium Acetate ACS reagent was dissolved in DDW 
and brought to a concentration of 10% (w/v). 
Iron Solution (Fisher Chemical Fair Lawn, NJ, USA): Iron reference solution, suitable 
for atomic absorption spectroscopy, at a concentration of 1000 ppm (as ferric nitrate 
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in 2% of nitric acid), was used to prepare the standards as well as to add to the protein 
samples as the source of extrinsic iron. 
Biuret Reagent: The reagent was prepared by separately dissolving 1.50g of CuSO4 • 
5H2O in 250 ml of DDW and 6.00g of sodium potassium tartrate (NaKC4O6 • 4H2O)4, 
in 250 ml of DDW. Both the solutions were mixed and 300 ml of 10% (w/v) NaOH 
was added and the final volume was made to 1 L with DDW. 
Bovine Serum Albumin (BSA): Crystalline and lyophilized bovine serum albumin 
prepared from fraction V, essentially globulin-free. (Sigma Chemical Co. St. Louis, 
MO, USA A-7906). BSA was dissolved in DDW and made to concentrations ranging 
from 1-10 mg/ml when used as a reference protein in the protein standards. 
 
III.C Apparatus 
 
Glassware: All glassware was acid washed with 2N HCl, rinsed with DDW several 
times and oven dried. 
Spectrophotometer: Perkin Elmer, Hitachi Model 200 UV-Vis, Coleman Instruments 
Division, Oak Broo, IL, USA. 
Low Speed Centrifuge: Bench top centrifuge Damon IEC model HN-S II. 
High Speed Centrifuge: Sorvall Superspeed RC-58 Automatic refrigerated centrifuge, 
Ivan Sorvall Inc., Newton, CT, USA. 
pH Meter: Corning, Model 125, Corning Medical, Medfield, MA, USA with an epoxi 
body combination electrode, Sensorex, Stanton, CA, USA. 
Water Bath Shaker: Temperature controlled, Model 406015 Serial, American Optical, 
Buffalo, NY, USA. 
Blender: Waring Commercial Blender, Model # 51BL31, Torrington, CT, USA. 
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Freeze Dryer: Virtis Company Inc, Model # 203314, Garinder, NY, USA.  
Chest Freezer: So-Low, Environmental Equipment Company, Cincinnati, OH, USA. 
 
III.D. Sample preparation: 
 
III.D.1. Raw Chicken Muscle Sample: 
 
Fresh, unfrozen chicken was purchased from local supermarket and the fat was 
removed. This sample was homogenized with twice the weight of water for 3 min 
with 1 min interval. After homogenization, 100g of sample was poured into container 
and frozen to -40oC in a chest freezer.  
 
III.D.2. Cooked Chicken Muscle Sample: 
 
Fresh, unfrozen chicken was purchased from local supermarket and the fat was 
removed. This sample was homogenized with twice the amount of water for 3 min 
with 1 min interval. This slurry was heated in a boiling water bath till the temperature 
reached 165 or 195oF with continuous stirring to maintain the uniform temperature of 
the sample. Then the sample was again homogenized for 30 sec and 100g of sample 
was poured into 1 pound plastic container, ~1 cm thick and frozen to -40oC in a chest 
freezer.  
 
The frozen samples were lyophilized using a Virtis company lyophilizer, at -40oC 
with increase of 10oC every hour till the temperature reached 20oC and this 
temperature was maintained until the sample was dried thoroughly. The lyophilization 
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time for raw and cooked sample was 72 hrs and 48 hrs respectively. The end point 
was when the chicken layer started sticking (puffing) out from the surface of the 
container.  
 
A detailed outline for the preparation of the sample is shown in following figure. 
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Figure III.D.2.1: Outline for lyophilization of raw and cooked chicken muscle sample 
Chicken Breast Muscle 
Remove Fat 
Homogenize (~ 3 min with one min 
interval) 
Fill In Containers 
Freeze to -400C 
Lyophilize 
Cook in boiling water bath at 
1650F/195oF (0.75lb/~ 50 
mins) 
Homogenize ~30 secs 
Fill in containers (0.8-1.0cm 
height) 
Cool to room temp ~30 min  
Freeze to -400C 
 
Lyophilize 
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After lyophilization, the sample was removed from the container and blended for 1 
min in a coffee blender and analyzed for protein content using Micro Dumas method 
(Ma and Rittner 1979).  
 
III.E. Pepsin digestion: 
 
The portion of the sample containing 2g of protein was mixed with DDW and the 
weight was adjusted to ~ 90g, following which the pH of the suspension was adjusted 
to 2.5 using 6.0 M HCl. 37.5 µM (1.4 ml) of Iron reference solution was added to this 
suspension. The pH of this suspension was adjusted to 2.0 and the weight was 
adjusted to 95g. This preparation was allowed to stand for 10mins. The final pH was 
rechecked and adjusted to 2.0, if required. The sample at pH 2.0 was then placed in a 
shaking water bath at 37oC for 5 mins. After this, 5ml of pepsin was added and the 
suspension was incubated at 37oC for 2 hrs. Three similar digests of 100g were 
incubated simultaneously in the same water bath. After pepsin digestion, the sample 
was removed from the water bath and placed in a ice bath to stop the pepsin digestion. 
 
III.F. Titratable acidity: 
 
Titratable acidity is the amount of 0.5 N NaOH required to bring the pH of pepsin-
digested sample to 6.5. The equivalent moles of NaHCO3 are then added to the actual 
digest to bring the pH to 6.5. 
A 20g aliquot of the pepsin-digested sample from each of the 100g flask was taken 
and 5 ml of pancreatin and bile in PIPES at pH 6.5 was added. The pH of this 
suspension was then adjusted to 6.5 using 0.5N NaOH drop-wise. The suspension was 
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allowed to stand for 10 min and the pH was readjusted to 6.5. The total amount of 
NaOH required for this was used to calculate the equivalent moles of NaHCO3 
required in 20 ml of the solution to be added to the dialysis tubing to bring the pH to 
6.5. 
 
III.G. Pancreatin digestion: 
 
For pancreatin digestion two 20g samples of the pepsin-digested sample from each 
flask were taken in 250 ml conical flasks, thus giving a total of six pancreatin 
digestions. Dialysis tubing, 20 cm in length and containing 20 ml NaHCO3 solution at 
the concentration determined by titratable acidity were added to the flasks. After 30 
min of incubation at 37oC the pH was recorded and 5 ml of pancreatin/bile salt in 
PIPES was added to each of the flasks incubated at 37oC for 2 hrs. 
Following which the digests were removed and the contents inside and outside the 
dialysis bags were weighed. The final pHs of the dialyzate and non-dialyzate were 
recorded. 
 
Analysis: 
 
After the completion of pancreatin digestion, both the dialyzate and the non-dialyzate 
were weighed and centrifuged at 1800 x g for 10 mins. Following which an aliquot 
from each of the samples was mixed with non-reducing solution at 1:1 ratio (v/v). 
These samples were used to quantify the amount of dialyzable ferrous and total 
ferrous iron produced during the digestion process. Similarly an aliquot of each of the 
samples was mixed with reducing solution at 1:1 ratio (v/v). These samples were used 
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to quantify the amount of total dialyzable and soluble iron produced during the 
digestion process. A reagent control was also prepared with the same ratio of reducing 
and non-reducing solutions with the dialyzate or non-dialyzate being replaced by 
DDW. These samples were covered and left on the bench at room temperature for 
analysis of iron and protein on the following day. 
 
All the samples were centrifuged. The samples containing the dialyzable portion were 
centrifuged at 3500 RPM for 10 mins using the bench top laboratory centrifuge, while 
the samples containing the non-dialyzable portion were centrifuged at 9,000 x g for 20 
mins. 
 
III.H. General Analysis Methods: 
 
III.H.1. Dialyzable Ferrous Iron: 
 
This represents the amount of dialyzable iron present in the ferrous form. This is the 
most potentially bioavailable form of iron and so is the best indicator of potentially 
bioavailable iron in in-vitro studies. 
 
For the determination of dialyzable ferrous iron, 1ml aliquot of the samples having a 
1:1 ratio of dialyzable digest : non-reducing solution, were taken in acid washed test 
tubes. To this 2 ml of 10% ammonium acetate buffer was added, followed by the 
addition of 0.5 ml of Ferrozine reagent. The mixture was mixed with a vortex and the 
absorbance was measured immediately at 562 nm. 
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III.H.2. Dialyzable Total Iron: 
 
This represents the amount of dialyzable iron present in both the ferrous and the ferric 
form. This is the indicator of the amount of absorbable iron as this is the iron bound to 
the low molecular weight ligands and so gets easily dialyzed through the 6,000 - 
8,000 Da cut off dialysis tubing. 
 
For the determination of dialyzable total iron, 1ml aliquot of the samples having a 1:1 
ratio of dialyzable digest : reducing solution, were taken in acid washed test tubes. To 
this 2 ml of 10% ammonium acetate buffer was added, which was followed by the 
addition of 0.5 ml of Ferrozine reagent. The mixture was mixed using a vortex, 
allowed to stand at room temperature for one hour, and then the absorbance was 
measured at 562 nm. 
 
III.H.3. Non-dialyzable Ferrous Iron: 
 
This represents the amount of iron being converted to the ferrous form but was not 
dialyzable. This is an excellent indicator of the ability of the test protein or any other 
component of investigation, to convert ferric iron to the ferrous form, which is the 
most potentially bioavailable form of iron. 
 
For the determination of non-dialyzable ferrous iron, 1ml aliquot of the samples 
having a 1:1 ratio of non-dialyzable digest : non-reducing solution, were taken in acid 
washed test tubes. To this 2 ml of 10% ammonium acetate buffer was added, followed 
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by the addition of 0.5 ml of Ferrozine reagent. The mixture was mixed with a vortex 
and the absorbance was measured immediately at 565 nm. 
 
III.H.4. Non-dialyzable Total Iron: 
 
This represents the amount of iron being converted to the soluble form but was not 
dialyzable. This is an excellent indicator of the ability of the test protein or any other 
component of investigation, to prevent polymerization of iron and convert it to the 
soluble form, which is one of the prerequisites for the iron to become potentially 
bioavailable. 
 
For the determination of non-dialyzable total iron, 1ml aliquot of the samples having a 
1:1 ratio of non-dialyzable digest : reducing solution, were taken in acid washed test 
tubes. To this 2 ml of 10% ammonium acetate buffer was added, followed by the 
addition of 0.5 ml of Ferrozine reagent. The mixture was mixed with a vortex, 
allowed to stand at room temperature for 1 hour and the absorbance was measured at 
565 nm. 
 
 
III.H.5. Dialyzable Protein: 
 
This represents the amount of protein, which has been finely digested and converted 
into peptides within the 6,000 to 8,000 Da range or less, and hence could not be 
precipitated by trichloroacetic acid (TCA). These are referred to as Low Molecular 
40 
 
Weight Components (LMWCO), and it is a prerequisite to bind iron and carry it along 
with them through the 6,000 - 8,000 Da cut off dialysis tubing. 
 
For the determination of dialyzable protein, 1 ml aliquot of the samples having a 1:1 
ratio of dialyzable digests : non-reducing solution, were taken in clean test tubes. To 
this 4 ml of biuret reagent was added. The mixture is thoroughly mixed with a vortex, 
allowed to stand at room temperature for 30 mins and the final absorbance was 
measured at 540 nm. A blank value was obtained with 1 ml distilled water and 4 ml of 
biuret reagent. 
 
III.H.6. Non-Dialyzable Protein: 
 
This represents the amount of protein, which has been completely digested and is 
greater than the 6,000 - 8,000 Da range, but could not be precipitated by trichloro 
acetic acid (TCA) and hence remains soluble. These are referred to as High Molecular 
Weight Components (LMWCO), and have tendency to bind iron but cannot carry the 
iron along with them through the 6,000 - 8,000 Da cut off dialysis tubing. 
For the determination of non-dialyzable protein, 1 ml aliquot of the samples having a 
1:1 ratio of non-dialyzable digests : non-reducing solution, were taken in clean test 
tubes. To this 4 ml of biuret reagent was added. The mixture was thoroughly mixed 
with a vortex, allowed to stand at room temperature for 30 mins. and the final 
absorbance was measured at 540 nm. A blank value was obtained with 1 ml distilled 
water and 4 ml of biuret reagent. 
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III.H.7. Sulfhydryl Analysis: 
 
The total sulfhydryl content of lyophilized raw and cooked (165oF and 195oF) sample 
was determined using Ellman’s method (Ellman 1959). Protein at a concentration of 
2mg/ml was dissolved in Na-phosphate buffer pH 8.0. 2ml of this sample was mixed 
with 18ml of 2.2% SDS in phosphate buffer pH 8.0. Ellman’s reagent (DTNB) at the 
concentration 0.1% was dissolved in phosphate buffer pH 8.0 and 0.1ml was added to 
3ml of blank/sample and the absorbance was read at 412 nm after 30 min against 
phosphate buffer. For the reagent blank, 3 ml of phosphate buffer was mixed with 0.1 
ml of Ellman’s reagent and the absorbance was read at 412nm against phosphate 
buffer and subtracted from each sample reading. 
  
III.8. Histidine Analysis: 
 
Histidine was analyzed using the method described by Seth and Mahoney (Seth and 
Mahoney, 2000). Protein at the concentration 10mg/ml was dissolved in phosphate 
buffer pH 6.5. 2ml of this sample was mixed with 18ml of 2.2% SDS in phosphate 
buffer pH 6.5. Diethyl-pyrocarbonate (DEPC) reagent at the concentration 20mM was 
dissolved in absolute (anhydrous) ethanol and 50 µl was added to the 1ml of 
blank/sample and the absorbance was read at 240nm after 30 min against phosphate 
buffer. For blank, 1 ml of phosphate buffer was mixed with 50 µl DEPC reagent and 
the absorbance was read at 240nm against phosphate buffer. 
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III.I. Controls: 
 
III.I.1. Iron Only Control: 
 
Digestion system without protein sample and enzymes was used carry out iron only 
control to compare the values with non-digested samples. The procedure was 
followed exactly as that mentioned above to obtain the values for dialyzable and non-
dialyzable iron. 
 
III.I.2. Iron-Pepsin control: 
 
Digestion system with pepsin and iron but without protein sample and pancreatin 
enzyme was used to get the values for dialyzable ferrous, dialyzable total, total 
ferrous and total soluble iron. The procedure was followed exactly as that mentioned 
above to get the respective values. 
 
III.I.3. Iron pepsin pancreatin control: 
 
Digestion system with pepsin, pancreatin enzymes and iron but without protein 
sample was used as control to ascertain the authenticity of the digestion processes and 
to calculate the extrinsic amount of iron that contributes to the measured values of 
iron after digestion. The procedure was followed exactly as that mentioned above to 
obtain values for dialyzable and non-dialyzable iron. 
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III.I.4. Endogenous Control: 
 
Endogenous control was used to estimate the contribution of intrinsic iron present in 
the samples. Digestion system with protein sample, pepsin and pancreatin enzymes 
and without standard iron solution was used to carry out endogenous control. The 
procedure was followed exactly as that mentioned above to obtain values for 
dialyzable and non-dialyzable iron and these values were subtracted from 
corresponding values for digested samples.  
 
III.I.5. Non-digested control: 
 
Non-digested control was used to estimate how much iron is produced without 
digestion of chicken muscle and to determine if digestion is important factor in iron 
bioavailability. For non-digested samples, the exact procedure as that of digestion was 
followed without adding any enzymes.  
 
III.J. Calculations: 
 
The amount of dialyzable and non-dialyzable matter obtained after each digestion 
were recorded and used to calculate dialyzable ferrous, total ferrous, total dialyzable 
and total soluble iron.  
 
As the dialysis process is known to be an equilibrium process, the amount of 
dialyzable iron is distributed equally in the entire volume of liquid present inside the 
dialysis tubing and in the non-dialyzate during digestion. So the total volume for the 
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dialysis would be 45 ml (20 ml for dialysis bag content, 20 ml for non-dialyzate and 5 
for PIPES/bile). 
 
Therefore the total volume of dialyzate (VD) = 45 ml. 
 
The amount of non-dialyzate always varies depending upon the dynamics of the 
system. If the sample contains very high amount of carbohydrates, then the osmotic 
pressure is very high and amount of liquid coming out of dialysis bag is high and 
vice-versa. So this amount is determined by weighing non-dialyzate and dialysis bag 
content. Assuming the density to be one, the same amount is taken as volume of non-
dialyzate and dialyzate produced. This volume generally varies from 26-28 ml. 
 
Therefore the total volume of dialyzate (VND) = 26-28 ml. 
 
The concentration of iron present in the dialyzate and non-dialyzate is calculated 
using ferrozine method as µg/ml, this can be represented as CFeF for ferrous and CFeT 
for total iron iron concentration. 
 
Therefore, 
Dialyzable ferrous iron = CFeF dialyzate * VD 
Non-dialyzable ferrous iron = CFeF non-dialyzate * VND 
Total dialyzable iron = CFeT dialyzate * VD 
Total non-dialyzable iron = CFeT non-dialyzate * VND 
 
And, 
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Total ferrous iron = Dialyzable ferrous iron + Non-dialyzable ferrous iron 
Total soluble iron = Total dialyzable iron + Total non-dialyzable iron. 
 
Similar calculation will be used to calculate the dialyzable protein and total protein 
content after TCA precipitation.  
46 
 
CHAPTER IV 
EFFECT OF FREEZING AND LYOPHILIZATION ON PRODUCTION OF 
DIALYZABLE IRON BY RAW CHICKEN MUSCLE 
 
IV.A. Introduction: 
 
Literature survey showed that most of the researchers used lyophilized meat samples 
to maintain the uniformity of samples throughout the study (Baech et al. 2002). Also, 
there is no data showing the effect of individual processes like freezing and 
lyophilization on iron bioavailability of chicken muscle samples. Sulfhydryl groups (-
SH) (Hoffman and Hamm 1978) and cysteine (Taylor et al. 1986) containing peptides 
of meat have been suggested to be responsible for ‘meat factor’. The effect of freezing 
and lyophilization on these factors is not mentioned in the literature. Freezing and 
lyophilization processes are very complex, and may cause some structure-
conformational changes and oxidation of –SH groups in the chicken muscle, because 
of which the ability of chicken muscle to produce potentially bioavailable forms of 
iron may be affected.  
 
Taking above factors into account, this chapter will focus on the effect of freezing and 
lyophilization on production of dialyzable iron, an important marker of potentially 
bioavailable form of iron in in-vitro studies. Slurry of raw chicken muscle sample was 
formed as mentioned in methods and it was divided into three batches. One batch was 
kept refrigerated, one was frozen at -40oC and one was lyophilized. The values for 
dialyzable iron were obtained and compared.  
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IV.B. Materials and Methods: 
 
IV.B.1. Chemicals: 
 
As discussed in Chapter III except for freshly prepared,  
 
Pepsin: Pepsin from porcine stomach mucosa (Sigma Chemical Co. St. Louis, MO, 
USA), P-7012, was prepared by dissolving 100mg in 5 ml of 0.01N HCl. Pepsin was 
added to the protein samples at a pepsin:protein ratio of 1:25 (w/w). 
 
Pancreatin: Pancreatin from porcine pancreas (Sigma Chemical Co. St. Louis, MO, 
USA), P-1750, was prepared by suspending 200 mg in 50 ml of 0.1M PIPES/bile, at 
pH 6.5. Pancreatin was added to the protein samples at a pancreatin:protein ratio of 
1:50 (w/w) 
 
PIPES/Bile: PIPES (Piperazine-N, N’-bis[2-ethanesulfonic acid]) disodium salt 
(Sigma Chemical Co. St. Louis, MO, USA). PIPES, P-3768, was dissolved in DDW 
at a concentration of 0.1M and the final pH was adjusted to 6.5. BILE salts, at the 
concentration of 50mg/ml, were dissolved in 50 ml of this buffer. 
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IV.B.2. Sample Preparation and Digestion Protocol: 
 
As described in chapter III, except where specifically noted. 
 
IV.C. General Analysis Methods: 
 
As described in chapter III, except where specifically noted. 
 
IV.D. Controls: 
 
As described in chapter III, except where specifically noted. 
 
 
IV.E. Results and Discussion 
 
This section presents the iron and protein values of refrigerated, frozen and 
lyophilized raw and chicken samples in comparison with control. The endogenous 
control values were subtracted from each digested sample.  
 
Table 1 shows the values for total sulfhydryl and histidine content of refrigerated, 
frozen and lyophilized raw chicken muscle sample. 
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SAMPLE 
 
 
Total –SH Content in  
mM/g Protein 
 
 
Total Histidine Content in 
mM/g Protein 
 
Refrigerated 
 
 
131.7 ± 7.96 a 
 
161.6 ± 3.25 c 
 
Frozen 
 
 
124.8 ± 6.58 a 
 
162.0 ± 1.99 c 
 
Lyophilized 
 
 
96.0 ± 4.23 b 
 
150.0 ± 3.31 d 
 
Table IV.E.1: Total sulfhydryl and histidine content for refrigerated, frozen and 
lyophilized raw chicken muscle samples. Mean ± SD of total sulfhydryl and histidine 
content of 6 samples (n = 6) in mM/g protein. Different subscripts indicates difference 
using One Way ANOVA test for α = 0.05 or 95% confidence.  
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Figure IV.E.1: Total sulfhydryl and histidine content of refrigerated, frozen and 
lyophilized raw chicken muscle samples. Graphical representation of the data from 
table 1. 
 
The total sulfhydryl and histidine content of refrigerated, frozen and lyophilized raw 
chicken muscle sample is shown in figure 1. There was no significant difference 
between total sulfhydryl and histidine content of refrigerated and frozen raw CMS. 
However, there was a significant loss of 32% for total sulfhydryl content after 
lyophilization of raw chicken muscle. Also, the histidine content of raw chicken 
dropped by ~6% after lyophilization. These results indicated that lyophilization causes 
a significant loss in sulfhydryl content, which may be either due to polymerization of 
proteins because of loss of water or due to oxidation of –SH groups during 
lyophilization. These results also showed that there was a drop in histidine content for 
raw chicken after lyophilization, which is the new finding as it is not mentioned 
anywhere in the literature.  
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Table 2 shows the values for total dialyzable iron and dialyzable ferrous iron 
produced by non-digested raw chicken sample for refrigerated, frozen and lyophilized 
treatments.  
 
 
 
 
 
SAMPLE 
 
 
Total Dialyzable iron in  
µg  
 
 
Dialyzable Ferrous Iron in  
µg  
 
Control 
 
3.4 ± 0.52 a 2.0 ± 0.46 d 
Refrigerated 
 
38.1 ± 1.83 b 16.8 ± 1.21 e 
Frozen 
 
34.2 ± 0.89 b 15.1 ± 0.90 e 
Lyophilized 
 
19.4 ± 0.45 c 3.8 ± 0.96 a 
 
Table IV.E.2: Total dialyzable iron and dialyzable ferrous iron produced by non-
digested control and raw refrigerated, frozen and lyophilized chicken muscle samples. 
Mean ± SD of total dialyzable iron [Fe (II) + Fe (III)] and dialyzable ferrous iron in 
µg for total 6 pancreatin digestions (n = 6). The total amount of iron used for each 
pancreatin digestion is 279 µg. Different subscripts indicates difference using One 
Way ANOVA test for α = 0.05 or 95% confidence. Endogenous iron produced by the 
same amount of samples has been subtracted from all the values. 
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Figure IV.E.2: Production of total dialyzable iron and dialyzable ferrous iron by non-
digested control and raw refrigerated, frozen and lyophilized chicken muscle samples. 
Graphical representation of the data from table 2. TDI: Total Dialyzable Iron; DFI: 
Dialyzable ferrous iron. 
 
 
The total dialyzable iron and dialyzable ferrous iron produced by non-digested 
samples of raw refrigerated, frozen and lyophilized CMS is shown in figure 2. Raw 
refrigerated and frozen chicken produced about 11 times higher amount of total 
dialyzable iron as that of control. Lyophilization of raw CMS caused a significant loss 
of ~50% for total dialyzable iron. Dialyzable ferrous iron produced by refrigerated 
and frozen raw chicken was 8 times higher than that of control. After lyophilization of 
raw chicken only 25% of dialyzable ferrous iron was produced as compared to 
refrigerated and frozen chicken sample. The values obtained for non-digested samples 
are much higher that control, which indicates that chicken muscle doesn’t need 
digestion to produce potentially bioavailable forms of iron. These results also showed 
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that lyophilization of raw CMS caused a significant loss in total dialyzable iron and 
dialyzable ferrous. This implied that the factor(s) responsible for production of 
dialyzable iron, which does not need digestion, is sensitive to lyophilization. This 
result is in contradiction with one obtained by Huh et al. (Huh et al. 2005), who 
concluded that digestion of lyophilized fish muscle did not affect its ability to produce 
dialyzable iron. The loss in production of dialyzable iron for non-digested sample 
could be attributed to the 32% loss of sulfhydryls and 15% loss of histidine, if there 
are any low molecular weight peptides containing these amino acids are present in the 
raw chicken, as it is shown that low molecular weight peptides containing these amino 
acids have ability to chelate iron (Hamed et al. 1983; Mulvihill and Morrissey, 1998; 
Swain et al. 2002). 
 
Table 3 shows the values for total soluble iron and total dialyzable iron produced by 
digested raw chicken sample for refrigerated, frozen and lyophilized treatments.  
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SAMPLE 
 
 
Total Soluble iron in  
µg  
 
 
Total Dialyzable iron in  
µg  
 
Control 
 
131.3 ± 9.67 a 6.5 ± 0.93 d 
Refrigerated 
 
121.3 ± 1.49 a 74.1 ± 3.21 e 
Frozen 
 
114.4 ± 2.64 b 70.4 ± 2.01 e 
Lyophilized 
 
88.7 ± 5.11 c 24.5 ± 1.73 f 
 
Table IV.E.3: Total soluble iron and total dialyzable iron produced by digested 
control and raw refrigerated, frozen and lyophilized chicken muscle samples. Mean ± 
SD of total soluble and total dialyzable iron [Fe (II) + Fe (III)] in µg for total 6 
pancreatin digestions (n = 6). The total amount of iron used for each pancreatin 
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA 
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount 
of samples has been subtracted from all the values. 
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Figure IV.E.3: Production of total soluble iron and total dialyzable iron by digested 
control and raw refrigerated, frozen and lyophilized chicken muscle samples. 
Graphical representation of the data from table 3. TSI: Total Soluble Iron; TDI: Total 
Dialyzable Iron. 
 
 
 
Figure 3, shows that the total soluble iron and total dialyzable iron produced by 
control and raw refrigerated, frozen and lyophilized chicken muscle sample (CMS). 
The total soluble iron produced by refrigerated raw CMS is not significantly different 
from frozen raw and CMS, which implies that freezing does not have any effect on 
chicken muscle’s ability to keep iron soluble under gastric conditions. But, the total 
soluble iron for lyophilized raw CMS is significantly different from that of 
refrigerated and frozen CMS (p<0.05), which indicated that lyophilization affects 
production of total soluble iron by raw CMS. This might be due to the structure-
conformational change in the protein structure caused by lyophilization. Total 
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dialyzable iron produced by refrigerated raw and frozen raw CMS is not significantly 
different from each other (p>0.05), which demonstrated that freezing does not affect 
digested chicken muscle’s ability to chelate iron and carry it through a 6000 – 8000 
Da dialysis membrane. But, there was ~65% drop in total dialyzable iron produced by 
lyophilized raw CMS when compared with refrigerated and frozen raw CMS, which 
implies that lyophilization has a major effect on chicken muscle’s ability to chelate 
iron and carry it through 6000 – 8000 Da membrane. This might be because of 
polymerization of proteins, which might have resulted in loss of sulfhydryl (-SH) 
groups or oxidation of –SH groups during lyophilization. Also the total dialyzable 
iron produced after digestion of raw CMS is much higher that non-digested raw CMS. 
This implies that chicken muscle does not need digestion to produce potentially 
bioavailable iron but digestion enhances its production significantly.  
 
Table 4 shows the values for total dialyzable iron and dialyzable ferrous iron 
produced by digested raw chicken sample for refrigerated, frozen and lyophilized 
treatments. 
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SAMPLE 
 
 
Total Dialyzable iron in  
µg  
 
 
Dialyzable Ferrous Iron in  
µg  
 
Control 
 
6.5 ± 0.93 a 2.8 ± 0.34 d 
Refrigerated 
 
74.1 ± 3.21 b 41.3 ± 2.04 e 
Frozen 
 
70.4 ± 2.01 b 40.9 ± 3.19 e 
Lyophilized 
 
24.5 ± 1.73 c 7.4 ± 1.38 a 
 
Table IV.E.4: Total dialyzable iron and dialyzable ferrous iron produced by digested 
control and raw refrigerated, frozen and lyophilized chicken muscle samples. Mean ± 
SD of total dialyzable iron [Fe (II) + Fe (III)] and dialyzable ferrous iron in µg for 
total 6 pancreatin digestions (n = 6). The total amount of iron used for each pancreatin 
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA 
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount 
of samples has been subtracted from all the values. 
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Figure IV.E.4: Production of total dialyzable iron and dialyzable ferrous iron by 
digested control and raw refrigerated, frozen and lyophilized chicken muscle samples. 
Graphical representation of the data from table 4. TDI: Total Dialyzable Iron; DFI: 
Dialyzable ferrous iron. 
 
The total dialyzable iron and dialyzable ferrous iron produced by digested control and 
raw refrigerated, frozen and lyophilized CMS is shown in figure 4. Total dialyzable 
iron and dialyzable ferrous iron produced by refrigerated raw and frozen raw CMS is 
not significantly different from each other (p>0.05), which implies that freezing 
chicken muscle did not impair any change in raw chicken’s ability to produce 
dialyzable ferrous iron and total dialyzable iron. But there was a drastic ~85% drop in 
dialyzable ferrous iron for lyophilized raw CMS as compared with refrigerated and 
frozen raw CMS, which indicated that lyophilization process almost destroyed the 
factor responsible for producing potentially bioavailable form of iron. It’s shown in 
the literature that sulfhydryl have ability to convert ferric [Fe (III)] form of iron to 
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ferrous form [Fe (II)], and the drop in dialyzable ferrous iron can be correlated with 
loss of sulfhydryl (-SH) groups. 
 
Table 5 shows the values for total ferrous iron and dialyzable ferrous iron produced 
by digested raw chicken sample for refrigerated, frozen and lyophilized treatments. 
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SAMPLE 
 
 
Total Ferrous Iron in  
µg  
 
 
Dialyzable Ferrous Iron in  
µg  
 
Control 
 
14.7 ± 0.85 a 2.8 ± 0.34 d 
Refrigerated 
 
76.1 ± 2.13 b 41.3 ± 2.04 e 
Frozen 
 
74.0± 1.51 b  40.9 ± 3.19 e 
Lyophilized 
 
23.2 ± 1.92 c 7.4 ± 1.38 f 
 
Table IV.E.5: Total ferrous iron and dialyzable ferrous iron produced by digested 
control and raw refrigerated, frozen and lyophilized chicken muscle samples. Mean ± 
SD of total ferrous iron and dialyzable ferrous iron in µg for total 6 pancreatin 
digestions (n = 6). The total amount of iron used for each pancreatin digestion is 279 
µg. Different subscripts indicates difference using One Way ANOVA test for α = 0.05 
or 95% confidence. Endogenous iron produced by the same amount of samples has 
been subtracted from all the values. 
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Figure IV.E.5: Production of total ferrous iron and dialyzable ferrous iron by digested 
control and raw refrigerated, frozen and lyophilized chicken muscle samples. 
Graphical representation of the data from table 5. TFI: Total Ferrous Iron; DFI: 
Dialyzable ferrous iron. 
 
Figure 5, shows that total ferrous iron and dialyzable ferrous iron produced by 
digested control and raw refrigerated, raw and frozen CMS. Dialyzable ferrous iron is 
already discussed in figure 5. The total ferrous iron produced by refrigerated and 
frozen raw CMS is not significantly different from each other, which again suggest 
that freezing does not impair any change in chicken muscle’s ability convert ferric [Fe 
(III)] form to ferrous [Fe (II)] form of the iron. But, similar to dialyzable ferrous iron, 
there is ~73% drop in total ferrous iron for lyophilized raw CMS as compared with 
refrigerated and frozen raw CMS, which indicated that lyophilization affected 
conversion of ferric form to ferrous form of iron. This may be attributed to the loss of 
sulfhydryl group caused by lyophilization, as sulfhydryl groups have ability to convert 
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ferric form to ferrous form. This indicated that –SH groups may play important role in 
conversion of ferric form of iron to ferrous form, as there is very strong correlation 
between the drops of –SH content and drop in total and dialyzable ferrous iron.  
 
Table 6 shows the values for total dialyzable iron and dialyzable ferrous iron 
produced due to digestion (Digested – Non-digested) by raw chicken sample for 
refrigerated, frozen and lyophilized treatments. 
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SAMPLE 
 
 
Total Dialyzable iron in  
µg  
 
 
Dialyzable Ferrous Iron in  
µg  
 
Control 
 
3.1 ± 0.93 a 0.7 ± 0.34 d 
Refrigerated 
 
36.0 ± 3.21 b 24.1 ± 2.04 e 
Frozen 
 
36.1 ± 2.01 b 25.7 ± 3.19 e 
Lyophilized 
 
5.1 ± 1.73 c 3.6 ± 1.38 a 
 
Table IV.E.6: Total dialyzable iron and dialyzable ferrous iron produced due to 
digestion (Digested – Non-digested) by control and raw refrigerated, frozen and 
lyophilized chicken muscle samples. Mean ± SD of total dialyzable iron [Fe (II) + Fe 
(III)] and dialyzable ferrous iron produced due to digestion in µg for total 6 pancreatin 
digestions (n = 6). The total amount of iron used for each pancreatin digestion is 279 
µg. Different subscripts indicates difference using One Way ANOVA test for α = 0.05 
or 95% confidence. Endogenous iron produced by the same amount of samples has 
been subtracted from all the values. 
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Figure IV.E.6: Production of total dialyzable iron and dialyzable ferrous iron due to 
digestion (Digested – Non-digested) by control and raw refrigerated, frozen and 
lyophilized chicken muscle samples. Graphical representation of the data from table 
6. TDI: Total Dialyzable Iron; DFI: Dialyzable ferrous iron. 
 
Figure 6 shows the effect of digestion only (non-digested iron values are subtracted 
from digested iron values for corresponding chicken muscle sample) on production of 
dialyzable iron and non-dialyzable iron by control, refrigerated, frozen and 
lyophilized raw chicken muscle. Refrigerated and frozen chicken muscle produced 
about 12 times as much dialyzable iron as that of control, whereas lyophilized chicken 
produced 1.5 times dialyzable iron as that of control. Also, the dialyzable ferrous iron 
produced by refrigerated and frozen chicken was 32 times as much as that of control 
and lyophilized chicken produced about 5 times dialyzable ferrous iron as that of 
control. 
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These results showed that almost 70% of total dialyzable iron produced during 
digestion is ferrous refrigerated, frozen and lyophilized chicken muscle sample. There 
is huge drop in total dialyzable and dialyzable ferrous iron produced by lyophilized 
chicken as compared to refrigerated and frozen chicken. This implies that the factor 
responsible for producing dialyzable forms of iron was affected significantly during 
lyophilization, but it was not destroyed completely as the values are higher than 
control. This can be attributed to the loss of –SH and histidine during lyophilization 
process. These results clearly showed that lyophilization has significant effect on 
chicken muscle’s ability to produce potentially bioavailable forms of iron. This might 
be due to the structure-conformational changes in chicken muscle protein because of 
loss of water during lyophilization process.  
 
Table 7 shows the values for total soluble protein and total dialyzable protein 
produced by digested raw refrigerated, frozen and cooked chicken muscle sample. 
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SAMPLE 
 
 
Total Soluble Protein in  
mg  
 
Total Dialyzable Protein in  
mg  
 
Refrigerated 
 
380.5 ± 5.32 a 295.3 ± 10.12 c 
Frozen 
 
384.8 ± 7.88 a 306.4 ± 11.81 bc 
Lyophilized 
 
320.5 ± 4.11 b 223.4 ± 12.48 d 
 
Table IV.E.7: Total soluble protein and total dialyzable protein values for digested 
raw refrigerated, frozen and lyophilized chicken muscle samples. Mean ± SD of total 
soluble protein and total dialyzable protein in mg for total 6 pancreatin digestions (n = 
6). Different subscripts indicates difference using One Way ANOVA test for α = 0.05 
or 95% confidence.  
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Figure IV.E.7: Production of total soluble protein and total dialyzable protein by raw 
refrigerated, frozen and lyophilized chicken muscle samples. Graphical representation 
of the data from table 6. TSP: Total Soluble Protein; TDP: Total Dialyzable Protein. 
 
 
The production of total soluble protein and total dialyzable protein by digested raw 
refrigerated, frozen and lyophilized CMS is shown in figure 7. There is no significant 
difference between refrigerated and frozen raw CMS on production of total soluble 
protein and total dialyzable protein. However, lyophilization caused small but 
significant change in production of dialyzable protein. However, lyophilization 
caused ~15% and ~25% drop in total soluble protein and total dialyzable protein, 
respectively as compared to refrigerated and frozen CMS. This indicates that 
lyophilization affects digestibility of chicken muscle. This may be due to the 
polymerization of chicken muscle protein during lyophilization, which made it 
difficult for the enzymes to break it down into small peptides and this may be one of 
the factor responsible for producing different amounts of potentially bioavailable iron. 
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IV.F. Conclusions: 
 
After this study, following conclusions can be made: 
 
 Chicken muscle does not need digestion to produce potentially bioavailable 
forms of iron. However digestion enhances its production significantly.  
 
 Freezing does not affect chicken muscle’s ability to produce potentially 
bioavailable forms of iron. 
 
 Lyophilization causes significant loss in total sulfhydryl and histidine content, 
which may be due to the polymerization of muscle proteins during 
lyophilization. 
 
 Lyophilization decreases chicken muscle’s ability to produce potentially 
bioavailable forms of iron and this is well correlated with decrease in –SH and 
histidine content.  
 
 The digestibility of chicken muscle affected significantly after lyophilization. 
This may be due to the polymerization of chicken muscle protein, which made 
it difficult for the enzymes to break it down in smaller peptides. 
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CHAPTER V 
EFFECT OF COOKING ON IRON BIOAVAILABILITY OF CHICKEN 
MUSCLE 
 
V.A. Introduction: 
 
From preliminary work, it is clear that lyophilization has a significant effect on 
sulfhydryl content and ability of chicken muscle to produce potentially bioavailable 
forms of iron. However, freezing chicken muscle slurry did not cause any significant 
effect on sulfhydryl content and production on potentially bioavailable species of iron. 
As we want to maintain the uniformity of the sample throughout the study, chicken 
muscle slurry can be frozen as it does not affect its ability to produce potentially 
bioavailable forms of iron. It will be interesting to cook the chicken muscle sample at 
different temperatures and obtain the values for amino acid content and dialyzable 
iron and to find the correlation between them. 
 
This chapter will focus on effect of cooking chicken muscle at four different 
temperatures. Chicken muscle slurry was cooked at 130oF, 150oF, 165oF and 195oF in 
a boiling water bath, cooled to room temperature, poured into 1 pound plastic 
container and frozen at -40oC in a chest freezer. These samples were thawed overnight 
in the refrigerated and subjected to pepsin and pancreatin digestion and analyzed for 
dialyzable iron values. The dialyzable iron values will be compared with amino acid 
content to see if there is any correlation between them. Detailed procedure for sample 
preparation and analysis is described in Chapter III. 
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V.B. Materials and Methods: 
 
V.B.1. Chemicals: 
 
As discussed in Chapter III except for freshly prepared solutions described below:  
 
Pepsin: Pepsin from porcine stomach mucosa (Sigma Chemical Co. St. Louis, MO, 
USA), P-7012, was prepared by dissolving 100mg in 5 ml of 0.01N HCl. Pepsin was 
added to the protein samples at a pepsin:protein ratio of 1:25 (w/w). 
 
Pancreatin: Pancreatin from porcine pancreas (Sigma Chemical Co. St. Louis, MO, 
USA), P-1750, was prepared by suspending 200 mg in 50 ml of 0.1M PIPES/bile, at 
pH 6.5. Pancreatin was added to the protein samples at a pancreatin:protein ratio of 
1:50 (w/w) 
 
PIPES/Bile: PIPES (Piperazine-N, N’-bis[2-ethanesulfonic acid]) disodium salt 
(Sigma Chemical Co. St. Louis, MO, USA). PIPES, P-3768, was dissolved in DDW 
at a concentration of 0.1M and the final pH was adjusted to 6.5. BILE salts, at the 
concentration of 50mg/ml, were dissolved in 50 ml of this buffer. 
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V.B.2. Sample Preparation and Digestion Protocol: 
 
As described in chapter III, except where specifically noted. 
 
V.C. General Analysis Methods: 
 
As described in chapter III, except where specifically noted. 
 
V.D. Controls: 
 
As described in chapter III, except where specifically noted. 
 
V.E. Results and Discussion 
 
Table 1 shows the values for total sulfhydryl and histidine content of raw and cooked 
(130oF, 150oF, 165oF and 195oF) chicken muscle sample (CMS).  
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Sample Treatment Sulfhydryl content µM/g 
protein sample 
Histidine content µM/g 
protein sample 
 
Raw Chicken Muscle 
Sample 124.8 ± 6.58 a 
 
 
162.0 ± 1.99 f 
 
Cooked (130oF) 
 Chicken Muscle Sample 73.0 ± 1.89 b 
 
 
129.0 ± 1.57 a 
 
Cooked (150oF) 
 Chicken Muscle Sample 55.5 ± 0.97 c 
 
 
124.0 ± 0.32 a 
 
Cooked (165oF) 
 Chicken Muscle Sample 31.5 ± 2.65 d 
 
 
101.6 ± 11.27 g 
 
Cooked (195oF)  
Chicken Muscle Sample 27.3 ± 0.93 e 
 
 
83.2 ± 0.65 h 
 
Table V.E.1: Total sulfhydryl and histidine content for raw and cooked (130oF, 150oF, 
165oF and 195oF) chicken muscle samples in µM/g protein. Mean ± SD of total 
sulfhydryl and histidine content of 6 samples (n = 6). Different subscripts indicates 
difference using One Way ANOVA test for α = 0.05 or 95% confidence.  
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Figure V.E.1: Total sulfhydryl and histidine content of raw and cooked (130oF, 150oF, 
165oF and 195oF) chicken muscle samples. Graphical representation of the data from 
table 1. 
 
 
 
The effect of heating on the total sulfhydryl (-SH) and histidine content of raw and 
cooked CMS is shown in figure 1. There was a significant ~40% drop in total –SH 
and ~20% drop in histidine content was observed when the chicken muscle was 
heated to 130oF. When the chicken muscle was heated to 150oF, the total –SH and 
histidine content dropped further, by ~55% and ~23% respectively, as compared to 
raw. Heating chicken muscle to 165oF resulted in further reduction of 75% in total –
SH content and ~37% in histidine content as compared to raw CMS. Only 20% of 
original –SH content was left i.e. ~80% was destroyed, when the cooking temperature 
of 195oF was used. Also, the histidine contend was dropped to half of the original 
histidine content after heating the chicken muscle to 195oF.  
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These result indicated that sulfhydryls are very sensitive to heat. Heating chicken 
muscle at 130oF and 150oF caused a significant reduction in total –SH content. These 
results are in contradiction with those mentioned by Hoffman and Hamm (Hoffman 
and Hamm, 1978), who measured the accessible –SH content and stated that heating 
myofibrils from 86oF to 158oF causes increase in accessible –SH group because of 
unfolding of protein molecules. The increase in cooking temperature of chicken 
muscle from 165oF to 195oF caused further destruction of –SH content. These results 
are consistent with those obtained by Hoffman and Hamm (Hoffman and Hamm, 
1978), which mentioned that heating chicken muscle protein above 160oF results in 
the loss of –SH content. The results obtained for histidine content showed that 
histidine is also heat sensitive, but not as much as that of –SH. There is no data to 
compare the histidine results in literature as no one mentioned effect of heat on 
histidine content.  
 
Table 2, gives the values for total soluble iron and total dialyzable iron produced by 
digested control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle 
samples. 
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Sample Total Soluble Iron in  
µg 
 
Total Dialyzable iron 
in µg 
 
 
Mean ± SD 
[Fe (II) + Fe (III)] 
 
Control 
 
131.3 ± 9.67 a 
 
6.5 ± 0.93 g 
 
Raw Chicken 
 
114.4 ± 2.64 b 
 
70.4 ± 2.01 f 
 
Cooked (130oF) CMS 
 
98.8 ± 2.49 c 
 
55.0 ± 2.16 h 
 
Cooked (150oF) CMS 
 
89.8 ± 1.92 d 
 
 43.4 ± 1.14 i 
 
Cooked (165oF) CMS 
 
85.1 ± 1.56 e 
 
37.0 ± 0.99 j 
 
Cooked (195oF) CMS 
 
70.6 ± 5.04 f 
 
9.5 ± 0.76 k 
 
Table V.E.2: Total soluble iron and total dialyzable iron values for digested control, 
raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. Mean ± 
SD of total soluble and total dialyzable iron [Fe (II) + Fe (III)] in µg for total 6 
pancreatin digestions (n = 6). The total amount of iron used for each pancreatin 
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA 
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount 
of samples has been subtracted from all the values. 
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Figure V.E.2: Production of total soluble iron and total dialyzable iron by control, raw 
and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. Graphical 
representation of the data from table 2. TSI: Total Soluble Iron; TDI: Total Dialyzable 
Iron. 
 
 
The total soluble iron and total dialyzable iron produced by raw and cooked chicken 
muscle is shown in figure 2. Results showed that the total soluble iron produced by 
raw chicken was only slightly less than the control. In case of cooked 131oF chicken 
muscle, there was a significant ~25% drop in total soluble iron as compared to 
control. The total soluble iron decreased further with the increase in cooking 
temperature. There was ~41%, ~35% and ~46% drop in total soluble iron for cooked 
150oF, 165oF and 195oF chicken muscle respectively, as compared to control. The 
total dialyzable iron for raw chicken was 12 times higher than that of control, which 
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showed chicken muscle’s ability to promote iron bioavailability. Cooking caused drop 
in production of total dialyzable. Total dialyzable iron is further discussed in figure 3. 
These results indicated that cooking chicken muscle results in the loss of its ability to 
keep iron in the soluble form, which is a primary requirement to make iron potentially 
bioavailable. This may be due to the ability of soluble high molecular weight fraction 
(HMWF), which chelates iron and is then precipitated by TCA. This may be because 
the HMWF might contain histidine and cysteine containing peptides, as it is 
previously shown that they have ability to bind iron and keep it in the soluble form 
(Mulvihill and Morrissey, 1997; Seth and Mahoney, 2000; Swain et al. 2001) and 
figure 1 shows that histidine and –SH content drops with increase in cooking 
temperature. In conclusion, heating chicken muscle affects its ability to keep iron in 
soluble form. 
 
Table 3 gives the values for total dialyzable iron and dialyzable ferrous iron produced 
by digested control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle 
samples. 
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Sample Total Dialyzable Iron 
in µg  
Dialyzable Ferrous Iron 
in µg 
 
 
Mean ± SD 
 
 
Control 
 
6.5 ± 0.93 a 
 
2.8 ± 0.34 g 
 
Raw Chicken 
 
70.4 ± 2.01 b 
 
49.9 ± 3.19 c 
 
Cooked (130oF) CMS 
 
55.0 ± 2.16 c 
 
36.4 ± 1.43 e 
 
Cooked (150oF) CMS 
 
 43.4 ± 1.14 d 
 
16.6 ± 0.92 h 
 
Cooked (165oF) CMS 
 
37.0 ± 0.99 e 
 
13.4 ± 0.45 i 
 
Cooked (195oF) CMS 
 
9.5 ± 0.76 f 
 
 5.5 ± 0.32 a 
 
Table V.E.3: Total dialyzable iron and dialyzable ferrous iron values for digested 
control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. 
Mean ± SD of total dialyzable iron and dialyzable ferrous iron in µg for total 6 
pancreatin digestions (n = 6). The total amount of iron used for each pancreatin 
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA 
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount 
of samples has been subtracted from all the values. 
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Figure V.E.3: Production of total dialyzable iron and dialyzable ferrous iron by 
control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. 
Graphical representation of the data from table 3. TDI: Total Dialyzable Iron; DFI: 
Dialyzable Ferrous Iron. 
 
Total dialyzable iron and dialyzable ferrous iron produced by raw and cooked chicken 
muscle samples is shown in figure 3. Raw chicken produced about 11 times as much 
total dialyzable iron and 17 times dialyzable ferrous iron as that of control, which 
clearly shows that chicken muscle is very good enhancer of iron bioavailability. 
Heating chicken muscle to 130oF caused ~40% drop in total dialyzable iron and ~26% 
drop in dialyzable ferrous iron, as compared to raw chicken sample. When the 
cooking temperature was increased to 150oF, this resulted in 50% drop in total 
dialyzable iron and 60% drop in dialyzable iron as compared to raw chicken sample. 
Further heating the sample to 165oF and 195oF caused a significant ~70% and ~77% 
drop in total dialyzable iron respectively. The dialyzable ferrous iron decreased by 
75% and 90%, when the samples were heated to 165oF and 195oF. 
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These results clearly show that heating chicken muscle has very strong effect on its 
ability to produce potentially bioavailable forms of iron. The drop in total dialyzable 
and dialyzable ferrous iron at 130oF shows that the factor(s) responsible for 
production of potentially bioavailable forms of iron is very heat labile and gets 
affected even if the sample is heated to 130oF. Also, the drop in total dialyzable and 
dialyzable ferrous iron continues when further addition of heat. Figure 1 shows that 
total sulfhydryl (-SH) and histidine content is also affected with increasing cooking 
temperature. So there is a very strong correlation between the drops of –SH, histidine 
and potentially bioavailable forms of iron. As mentioned in the literature –SH groups 
have ability to reduce ferric form of iron to ferrous form, which is the most potentially 
bioavailable form of iron (Taylor et al. 1986; Kirwan et al. 1993; Mulvihill and 
Morrissey, 1998; Mulvihill et al. 1998). Also histidine containing peptides have 
ability to chelate iron (Seth and Mahoney, 2000). In conclusion, these results indicate 
that sulfhydryl and histidine containing peptides might be involved production of 
potentially bioavailable forms of iron, as there is a very strong correlation between the 
drops of –SH, histidine and iron values.  
 
Table 4 gives the values for total ferrous iron and dialyzable ferrous iron produced by 
digested control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle 
samples. 
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Sample Total Ferrous Iron 
in µg  
Dialyzable Ferrous Iron 
in µg 
 
 
Mean ± SD 
 
 
Control 
 
14.7 ± 0.85 a 
 
2.8 ± 0.34 g 
 
Raw Chicken 
 
90.0 ± 1.51 b 
 
49.9 ± 3.19 d 
 
Cooked (130oF) CMS 
 
55.4 ± 1.63 c 
 
36.4 ± 1.43 h 
 
Cooked (150oF) CMS 
 
46.1 ± 1.39 d 
 
16.6 ± 0.92 a 
 
Cooked (165oF) CMS 
 
25.7 ± 1.52 e 
 
13.4 ± 0.45 a 
 
Cooked (195oF) CMS 
 
20.3 ± 1.39 f 
 
 5.5 ± 0.317 i 
Table V.E.4: Total ferrous iron and dialyzable ferrous iron values for digested control, 
raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. Mean ± 
SD of total ferrous iron and dialyzable ferrous iron in µg for total 6 pancreatin 
digestions (n = 6). The total amount of iron used for each pancreatin digestion is 279 
µg. Different subscripts indicates difference using One Way ANOVA test for α = 0.05 
or 95% confidence. Endogenous iron produced by the same amount of samples has 
been subtracted from all the values. 
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Figure V.E.4: Production of total ferrous iron and dialyzable ferrous iron by control, 
raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. Graphical 
representation of the data from table 4. TFI: Total Ferrous Iron; DFI: Dialyzable 
Ferrous Iron. 
 
The total ferrous iron and dialyzable ferrous iron produced by digested control, raw 
and cooked chicken muscle samples is shown in figure 4. Raw chicken produced 
about six times as much total ferrous iron as that of control and 17 times dialyzable 
ferrous iron as that of control, which clearly showed chicken muscle’s ability to 
reduce ferric form of iron to ferrous form and make it potentially bioavailable. 
Cooking the sample at 130oF resulted in ~38% drop in total ferrous iron and ~25% 
loss in total dialyzable iron. Further cooking the sample at 150oF resulted in drop of 
total ferrous iron to half and dialyzable ferrous iron to one third as compared to raw 
chicken sample. Cooking temperatures of 165oF and 195oF resulted in collapse of 
total ferrous iron by approximately 75%, as compared with raw chicken. The 
83 
 
dialyzable ferrous iron dropped by 73% and 90% for cooked 165oF and 195oF chicken 
muscle respectively, as compared to raw chicken muscle.  
These results shows that cooking chicken even at 130oF results in the loss of 
potentially bioavailable forms of iron, which implies that the meat factor(s) is heat 
labile. The increase in cooking temperature from 130oF to 195oF results in significant 
drop in production of potentially bioavailable forms of iron. Dialyzable ferrous iron 
produced by cooked 195oF sample is higher than that of control, which implies that 
heating chicken muscle at 195oF did not destroy the meat factor(s) completely. From 
figure 1, it is clear that –SH and histidine content drops significantly and show that 
similar trend as that of total ferrous iron and total dialyzable iron. It is well know that 
–SH group has ability to reduce ferric form of iron to ferrous form (Taylor et al. 1986; 
Kirwan et al. 1993; Mulvihill and Morrissey, 1998; Mulvihill et al. 1998) and 
histidine containing peptides can chelate iron (Seth and Mahoney, 2000). So the loss 
of chicken muscle’s ability to produce potentially bioavailable forms of iron is well 
correlated with that of –SH and histidine content.  
In conclusion heating chicken muscle results in loss of its ability to produced 
potentially bioavailable forms of iron and –SH and histidine containing peptides 
might be responsible for ‘meat factor’. 
 
Table 5 gives the values for total dialyzable iron and dialyzable ferrous iron produced 
by non-digested control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken 
muscle samples. 
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Sample Total Dialyzable Iron 
in µg  
Dialyzable Ferrous Iron 
in µg 
 
 
Mean ± SD 
 
 
Control 
 
2.9 ± 0.44 a 
 
2.0 ± 0.46 a 
 
Raw Chicken 
 
34.2 ± 0.89 b 
 
15.1 ± 0.90 g 
 
Cooked (130oF) CMS 
 
30.0 ± 1.70 c 
 
20.9 ± 1.11 d 
 
Cooked (150oF) CMS 
 
20.5 ± 0.73 d 
 
10.9 ± 0.65 h 
 
Cooked (165oF) CMS 
 
6.0 ± 1.18 e 
 
2.0 ± 0.85 a 
 
Cooked (195oF) CMS 
 
4.0 ± 0.39 f 
 
2.5 ± 0.39 a 
 
Table V.E.5: Total dialyzable iron and dialyzable ferrous iron values for non-digested 
control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. 
Mean ± SD of total dialyzable iron and dialyzable ferrous iron in µg for total 6 
pancreatin digestions (n = 6). The total amount of iron used for each pancreatin 
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA 
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount 
of samples has been subtracted from all the values. 
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Figure V.E.5: Production of total dialyzable iron and dialyzable ferrous iron by non-
digested control, raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle 
samples. Graphical representation of the data from table 5. TDI: Total Dialyzable 
Iron; DFI: Dialyzable Ferrous Iron. 
 
 
 
The total dialyzable iron and dialyzable ferrous iron produced by non-digested raw 
and cooked sample is shown in figure 5. Non-digested raw chicken produced about 12 
times total dialyzable iron and 7 times dialyzable ferrous iron as that of control. The 
total dialyzable iron produced by cooked 130oF chicken sample dropped slightly by 
insignificant 10% as compared to control. The dialyzable ferrous iron increased by 
~30% as compared with raw chicken, which may be attributed to the unfolding of 
protein molecules and exposure of accessible –SH groups to the iron. There was drop 
in both total dialyzable iron and dialyzable ferrous iron by approximately 40% and 
33%, respectively for cooked 150oF chicken sample as compared with raw chicken. 
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When the sample was cooked at 165oF and 195oF, the total dialyzable iron collapsed 
by 82% and 88% respectively, as compared with raw chicken. The total ferrous iron 
was dropped by a very significant amount and was similar to that produced by 
control.  
These results show that chicken muscle does not need digestion to produce potentially 
bioavailable forms of iron. This implies that some of the ‘meat factor(s)’ is present in 
raw meat, which does not need digestion to produce potentially bioavailable forms of 
iron. However, from figure 3 it’s also clear that digestion helps to produce more 
potentially bioavailable iron, which implies that some of the ‘meat factor(s)’ is 
produced during digestion. The drop in total dialyzable iron and dialyzable ferrous 
iron for cooked samples indicates that the ‘meat factor(s)’ present in raw meat is very 
heat sensitive. The dialyzable ferrous iron for cooked 165oF and 195oF sample 
dropped to the level which is not significantly different from control.  
This implies that the ‘meat factor(s)’ present in raw meat, which does not need 
digestion to produce potentially bioavailable forms of iron, was destroyed completely 
when chicken was cooked at 165oF. However, from figure IV.E.3 it is clear that the 
total dialyzable iron and dialyzable ferrous iron produced by cooked 165oF and 195oF 
chicken sample is much higher than control. This implies that most of the ‘meat 
factor(s)’ for cooked 165oF and 195oF chicken sample was produced during digestion.  
In conclusion, the ‘meat factor’ present in raw meat, which does not need digestion to 
produce potentially bioavailable forms of iron, was destroyed completely when 
chicken was cooked at 165oF. 
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Table 6 gives the values for total dialyzable iron and dialyzable ferrous iron produced 
because of digestion (non-digested iron values are subtracted from the digested iron 
values for the corresponding sample) by control, raw and cooked (130oF, 150oF, 
165oF and 195oF) chicken muscle samples. 
 
 
Sample Total Dialyzable Iron 
in µg  
Dialyzable Ferrous Iron 
in µg 
 
 
Mean ± SD 
 
 
Control 
 
3.6 ± 0.93 a 
 
0.7 ± 0.34 f 
 
Raw Chicken 
 
36.1 ± 2.01 b 
 
34.7 ± 3.19 b 
 
Cooked (130oF) CMS 
 
25.0 ± 2.16 c 
 
15.4 ± 1.43 g 
 
Cooked (150oF) CMS 
 
 22.8 ± 1.14 c 
 
5.6 ± 0.92 h 
 
Cooked (165oF) CMS 
 
31.0 ± 0.99 d 
 
11.3 ± 0.45 i 
 
Cooked (195oF) CMS 
 
5.4 ± 0.76 e 
 
2.9 ± 0.32 a 
 
Table V.E.6: Total dialyzable iron and dialyzable ferrous iron produced due to 
digestion (digested iron – non-digested iron values) of control, raw and cooked 
(130oF, 150oF, 165oF and 195oF) chicken muscle samples. Mean ± SD of total 
dialyzable iron and dialyzable ferrous iron in µg for total 6 pancreatin digestions (n = 
6). The total amount of iron used for each pancreatin digestion is 279 µg. Different 
subscripts indicates difference using One Way ANOVA test for α = 0.05 or 95% 
confidence. Endogenous iron produced by the same amount of samples has been 
subtracted from all the values. 
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 Figure V.E.6: Production of total dialyzable iron and dialyzable ferrous iron due to 
digestion (digested iron – non-digested iron values) of control, raw and cooked 
(130oF, 150oF, 165oF and 195oF) chicken muscle samples. Graphical representation of 
the data from table 6. TDI: Total Dialyzable Iron; DFI: Dialyzable Ferrous Iron. 
 
 
The total dialyzable iron and dialyzable ferrous iron produced because of digestion 
(non-digested iron values are subtracted from the digested iron values for the 
corresponding sample) is shown in fig 6. Raw and cooked (130oF) chicken samples 
produced about 10 times and 7 times as much dialyzable iron as that of control, 
respectively, whereas cooked 150oF and 165oF chicken samples produced about 6 
times and 8 times total dialyzable iron as that of control, respectively. The total 
dialyzable iron produced by cooked 195oF chicken sample was slightly higher than 
control. In case of dialyzable ferrous iron, almost 100% dialyzable iron produced is 
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ferrous for raw chicken sample. But, the percentage of dialyzable ferrous iron 
produced by cooked samples decreases with temperature, except for cooked 165oF.  
These results clearly showed that digestion of chicken muscle does produce 
potentially bioavailable forms of iron and it’s in contradiction with the results 
obtained by Huh et al. (Huh et al. 2005) who suggested that digestion did not produce 
potentially bioavailable forms of iron. Also, the drop in production of total dialyzable 
and dialyzable ferrous iron with temperature is well correlated with the drop in –SH 
and histidine content for corresponding samples, which are suggested to be 
responsible for ‘meat factor’. 
 
Table 7 gives the values for total soluble protein and total dialyzable protein produced 
by lyophilized raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle 
samples. 
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Sample Total Soluble Protein  
in mg 
Total Dialyzable Protein  
in mg 
 
 
Mean ± SD 
 
 
Control 
 
- 
 
- 
 
Raw Chicken 
 
384.8 ± 7.88 a 
 
306.4 ± 11.81 d 
 
Cooked (130oF) CMS 
 
364.0 ± 8.67 b 
 
235.8± 8.24 e 
 
Cooked (150oF) CMS 
 
340.7 ± 3.56 c 
 
237.5 ± 8.46 e 
 
Cooked (165oF) CMS 
 
378.5 ± 10.29 ab 
 
265.0± 18.49 e 
 
Cooked (195oF) CMS 
 
386.3 ± 3.59 a 
 
322.5 ± 21.27 d 
 
Table V.E.7: Total soluble protein and total dialyzable protein values for digested raw 
and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. Mean ± SD of 
total soluble protein and total dialyzable protein in mg for total 6 pancreatin 
digestions (n = 6). The total amount of protein used for each pancreatin digestion is 
400 mg. Different subscripts indicates difference using One Way ANOVA test for α = 
0.05 or 95% confidence.  
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Figure V.E.7: Production of total soluble protein and total dialyzable protein by 
digested raw and cooked (130oF, 150oF, 165oF and 195oF) chicken muscle samples. 
Graphical representation of the data from table 7. TSP: Total Soluble Protein; TDP: 
Total Dialyzable Protein. 
 
The production of total soluble protein and total dialyzable protein by digested raw 
and cooked chicken muscle samples is shown in figure 7. Even if there is slight 
variation in total soluble protein produced by raw and cooked samples, there is no 
significant difference between them. Total soluble protein produced by raw and 
cooked chicken muscle samples are not significantly different from each other, which 
suggests that digestion of chicken muscle was uniform and was not a factor 
responsible for difference in the dialyzable iron produced. Total dialyzable protein 
produced by raw chicken muscle is higher than cooked 130oF, 150oF and 165oF and it 
is not significantly different from that of cooked 195oF chicken sample. These results 
suggest that cooking temperature plays important role in digestibility of chicken 
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muscle samples. At 195oF, the proteins may be denatured well enough to get digested; 
whereas at lower cooking temperature, the digestibility might have affected because 
of polymerization of proteins.  
 
V.F. Conclusions: 
 
After this study, following conclusion can be made: 
 
 Chicken muscle does not need digestion to produce potentially bioavailable 
forms of iron. But digestion increases the amount of potentially bioavailable 
forms of iron significantly.  
 
 Heating causes progressive decrease in production of dialyzable iron by both 
digested and non-digested chicken muscle samples. 
 
 The total dialyzable iron, which is an important marker of potentially 
bioavailable forms of iron in in-vitro study, dropped significantly with 
increase in cooking temperature and this drop is well correlated with the drop 
in sulfhydryl and histidine content. This suggests that sulfhydryl and histidine 
play an important role in ‘meat factor’. 
 
 The factor(s) responsible to convert ferric from of iron to ferrous is very heat 
labile. This can be correlated with the drop in total -SH content as –SH groups 
have ability to reduce ferric iron to ferrous form. 
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CHAPTER VI 
PRODUCTION OF DIALYZABLE IRON BY LYOPHILIZED RAW AND 
COOKED SAMPLES 
VI.A. Introduction: 
 
Literature survey suggests that effect of cooking chicken on production of potentially 
bioavailable forms of iron has not been given much attention. Cysteine containing 
peptides of meat, e.g. glutathione (Taylor et al. 1986) and sulfhydryl (-SH) and 
disulphide groups in meat (Hoffman and Hamm 1978), have been suggested to be 
responsible for ‘meat factor’, but the effect of cooking on these factors has not been 
given much emphasis. It is well known that sulfhydryls are heat labile and heating 
temperature plays important role in sulfhydryl degradation. Literature review 
indicates no such study where the effect on sulfhydryl and histidine content under 
cooking conditions is measured. We selected heating temperature as 165oF and 195oF. 
165oF is minimum temperature to kill microbes and 195oF is used for further heating 
reference temperature.  
 
Chicken muscle slurry was heated at 165 and 195oF in a boiling water bath, cooled to 
room temperature and 100g of raw and heated slurry was poured in 1 pound 
containers to the thickness of 1 cm. These samples were frozen to -40oC and 
lyophilized in a commercial lyophilizer. After lyophilization, the sample were stored 
at -15oC and used as required for the experiments. The amount of dialyzable iron 
formed, -SH and histidine content of each sample was analyzed using methods 
described in Chapter III and the results were compared with raw chicken values.  
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VI.B. Materials and Methods: 
 
VI.B.1. Chemicals: 
 
As discussed in Chapter III except for freshly prepared solutions below:  
 
Pepsin: Pepsin from porcine stomach mucosa (Sigma Chemical Co. St. Louis, MO, 
USA), P-7012, was prepared by dissolving 100mg in 5 ml of 0.01N HCl. Pepsin was 
added to the protein samples at a pepsin:protein ratio of 1:25 (w/w). 
 
Pancreatin: Pancreatin from porcine pancreas (Sigma Chemical Co. St. Louis, MO, 
USA), P-1750, was prepared by suspending 200 mg in 50 ml of 0.1M PIPES/bile, at 
pH 6.5. Pancreatin was added to the protein samples at a pancreatin:protein ratio of 
1:50 (w/w) 
 
PIPES/Bile: PIPES (Piperazine-N, N’-bis[2-ethanesulfonic acid]) disodium salt 
(Sigma Chemical Co. St. Louis, MO, USA). PIPES, P-3768, was dissolved in DDW 
at a concentration of 0.1M and the final pH was adjusted to 6.5. BILE salts, at the 
concentration of 50mg/ml, were dissolved in 50 ml of this buffer. 
 
VI.B.2. Sample preparation: 
 
As described in chapter III, except where specifically noted. 
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VI.C. Analysis: 
 
As discussed in chapter III, except where specifically noted. 
 
VI.D. Controls: 
 
As described in chapter III, except where specifically noted. 
 
VI.E. Results and Discussion 
 
This section presents the amino acid, iron and protein values of lyophilized raw and 
cooked (165oF and 195oF) samples in comparison with control. The endogenous 
control values were subtracted from each digested sample to obtain the values shown 
in this section. 
 
Table 1 gives the values for total sulfhydryl and histidine content of lyophilized raw 
and cooked (165oF and 195oF) chicken muscle samples (CMS). 
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Sample Sulfhydryl content µM/g 
protein sample 
Histidine content µM/g 
protein sample 
 
Lyophilized Raw  
CMS 89.7±3.78 a 
 
 
136.3±2.03 d 
 
Lyophilized Cooked (165oF) 
CMS 64.0±3.94 b 
 
 
99.7±3.72 e 
 
Lyophilized Cooked (195oF) 
CMS 40.2±2.17 c 
 
 
82.6±2.66 f 
 
Table VI.E.1: Total sulfhydryl and histidine content for lyophilized raw and cooked 
(165oF and 195oF) chicken muscle samples in µM/g protein. Mean ± SD of total 
sulfhydryl and histidine content of 6 samples (n = 6). Different subscripts indicates 
difference using One Way ANOVA test for α = 0.05 or 95% confidence.  
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Figure VI.E.1: Total sulfhydryl and histidine content of lyophilized raw and cooked 
(165oF and 195oF) chicken muscle samples. Graphical representation of the data from 
table 1. 
 
 
 
Figure 1, shows the sulfhydryl content for lyophilized raw and cooked samples (165oF 
and 195oF) is significantly different from each other (p<0.05). Sulfhydryl content of 
lyophilized cooked 165oF and 195oF CMS dropped by ~30% and ~55%, as compared 
with lyophilized raw samples respectively. This implies that sulfhydryls are heat 
labile and were degraded at 165oF and the degradation continued till 195oF. The effect 
of further heating is unknown to us as 195oF was highest temperature of heating for 
our study. The histidine values were also dropped by ~30 % and ~40% for lyophilized 
cooked 165oF and 195oF CMS respectively, when compared with raw CMS. The 
effect of heating on histidine is not mentioned in anywhere in literature. This implies 
that histidine is also heat labile and may be a factor responsible for drop in dialyzable 
total iron.  
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Table 2, gives the values for total soluble iron and total dialyzable iron produced by 
digested control, lyophilized raw and cooked (165oF and 195oF) chicken muscle 
samples. 
 
 
 
Sample Total soluble iron in  
µg 
Total dialyzable iron in 
µg 
 
 
 
Mean ± SD 
 
 
Control 
 
131.3 ± 9.67 a 
 
6.5 ± 0.93 d 
 
Raw Chicken 
 
88.7 ± 5.11 b 
 
24.5 ± 1.73 e 
 
Cooked (165oF) chicken 
 
79.6 ± 6.87 b 
 
21.7 ± 0.90 f 
 
Cooked (195oF) chicken 
 
64.1 ± 3.36 c 
 
21.1 ± 1.27 f 
 
Table VI.E.2: Total soluble iron and total dialyzable iron values for no protein 
control, lyophilized raw and cooked (165oF and 195oF) chicken muscle samples. 
Mean ± SD of total soluble and total dialyzable iron [Fe (II) + Fe (III)] in µg for total 
6 pancreatin digestions (n = 6). The total amount of iron used for each pancreatin 
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA 
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount 
of samples has been subtracted from all the values. 
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Figure VI.E.2: Production of total soluble iron and total dialyzable iron by control, 
lyophilized raw and cooked (165oF and 195oF) chicken muscle samples. Graphical 
representation of the data from table 2. TSI: Total Soluble Iron; TDI: Total Dialyzable 
Iron. 
 
 
 
Figure 2, indicates the total soluble iron produced by digested control and lyophilized 
raw and cooked (165oF and 195oF) are significantly different (p<0.05). The total 
soluble iron is dropped by ~32% in case of lyophilized raw, ~40% in case of cooked 
(165oF) and ~50% in case of cooked (195oF) chicken muscle sample as compared to 
control. This can be attributed to the high molecular weight fractions from chicken 
muscle samples, which bind iron and then precipitated when TCA was added. This 
suggests that the fraction which was not digested completely (high molecular weight 
fraction) bound large amount of inorganic iron and it was precipitated by TCA. This 
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may be due to heat induced  polymerization of proteins, which reduced the 
digestibility of chicken. The total dialyzable iron values for lyophilized raw and 
cooked (165oF and 195oF) are very distinct from control (p<0.05). The total 
dialyzable iron produced by uncooked chicken is slightly higher than cooked CMS. 
However, the total dialyzable iron produced by cooked 165oF and cooked 195oF CMS 
is not significantly distinct from each other. This suggested that heating chicken from 
165 to 195oF did not cause any further drop in total dialyzable iron, even though the 
total sulfhydryl and histidines dropped. Total dialyzable iron is further discussed in 
figure 3. 
 
 
Table 3 gives the values for total dialyzable iron and dialyzable ferrous iron produced 
by no protein control, lyophilized raw and cooked (165oF and 195oF) chicken muscle 
samples. 
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Sample Total dialyzable iron in 
µg 
 
 
Dialyzable ferrous iron 
in µg 
 
 
Mean ± SD 
 
 
Control 
 
6.5 ± 0.93 a 
 
2.8 ± 0.34 c 
 
Raw Chicken 
 
24.5 ± 1.73 b 
 
7.4 ± 1.38 d 
 
Cooked (165oF) chicken 
 
21.7 ± 0.90 b 
 
7.2 ± 0.55 d 
 
Cooked (195oF) chicken 
 
21.1 ± 1.27 b 
 
4.2 ± 1.50 c 
 
Table VI.E.3: Total dialyzable iron and dialyzable ferrous iron values for digested 
control, lyophilized raw and cooked (165oF and 195oF) chicken muscle samples. 
Mean ± SD of total dialyzable [Fe (II) + Fe (III)] and dialyzable ferrous iron [Fe (II)] 
in µg for total 6 pancreatin digestions (n = 6). The total amount of iron used for each 
pancreatin digestion is 279 µg. Different subscripts indicates difference using One 
Way ANOVA test for α = 0.05 or 95% confidence. Endogenous iron produced by the 
same amount of sample has been subtracted from all the values. 
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Figure VI.E.3: Production of total dialyzable iron and dialyzable ferrous iron by 
digested control, lyophilized raw and cooked (165oF and 195oF) chicken muscle 
samples. Graphical representation of the data from table 3. TDI: Total Dialyzable 
Iron; DFI: Dialyzable ferrous Iron. 
 
 
Figure 3, indicates the comparison between total dialyzable iron and dialyzable 
ferrous iron produced by digested chicken muscle samples. Total dialyzable iron is ~4 
times higher for lyophilized raw chicken muscle samples and ~3 times higher for 
lyophilized cooked chicken muscle samples (165oF and 195oF). This proves the 
previous findings that chicken muscle plays important role in production of 
potentially bioavailable forms of iron (Hallberg, 1981; Berner and Miller, 1985; 
Carpenter and Mahoney 1992; Seth and Mahoney, 2000). The total dialyzable iron 
values for lyophilized cooked (165oF and 195oF) chicken muscle samples (CMS) are 
not distinct from lyophilized raw CMS (p<0.05), which indicates that heating does not 
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affects chicken muscle’s ability to produce potentially bioavailable forms of iron and 
the factor(s) responsible for producing potentially bioavailable forms of iron is not 
heat labile. Total dialyzable iron values for lyophilized cooked 165oF sample and 
lyophilized cooked 195oF sample are not distinct (p>0.05) from each other. This 
suggests that the factor(s) responsible for producing potentially bioavailable forms of 
iron was degraded at 165oF, but heating it further to 195oF has no effect on these 
factor(s). The findings for cooked samples are in consistent with those obtained by 
Baech et al. (Baech et al. 2002), which suggested that increasing cooking temperature 
of ham does not have any effect on iron bioavailability in-vivo. But the values for total 
dialyzable iron for cooked samples are ~3 times higher than that of no protein control, 
which implies that the factor(s) responsible for producing potentially bioavailable 
forms of iron was affected slightly. Nearly 30% of the total dialyzable iron is ferrous 
in case of lyophilized raw and cooked (165oF) CMS and nearly 20% of total 
dialyzable iron is in ferrous form for cooked 195oF CMS. This indicates that only one 
third of the total dialyzable iron was reduced to ferrous form, which is the most 
potentially bioavailable form of iron and two third remained ferric. The marked 
decrease in dialyzable ferrous iron for 195oF cooked sample may be correlated with 
the ~55% drop in sulfhydryl content.  
 
Overall, these results show that cooking does not have any prominent effect on 
production of dialyzable iron species, except for dialyzable ferrous iron at 195oF, 
despite the drop in –SH and histidine content.  
 
Table 4 gives the values for total ferrous iron and dialyzable ferrous iron produced by 
no protein control, lyophilized raw and cooked (165oF and 195oF) chicken muscle 
samples.  
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Sample Total ferrous iron in  
µg 
Dialyzable ferrous iron in 
µg 
 
 
 
Mean ± SD 
 
 
Control 
 
14.7 ± 0.85 a 
 
2.8 ± 0.34 c 
 
Raw Chicken 
 
23.2 ± 1.92 b 
 
7.4 ± 1.38 d 
 
Cooked (165oF) chicken 
 
22.5 ± 1.54 b 
 
7.2 ± 0.55 d 
 
Cooked (195oF) chicken 
 
20.7 ± 3.76 b 
 
4.2 ± 1.50 c 
 
Table VI.E.4: Total ferrous iron and dialyzable ferrous iron values for digested 
control, lyophilized raw and cooked (165oF and 195oF) chicken muscle samples. 
Mean ± SD of total ferrous [Fe (II)] and dialyzable ferrous iron [Fe (II)] in µg for total 
6 pancreatin digestions (n = 6). The total amount of iron used for each pancreatin 
digestion is 279 µg. Different subscripts indicates difference using One Way ANOVA 
test for α = 0.05 or 95% confidence. Endogenous iron produced by the same amount 
of sample has been subtracted from all the values. 
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Figure VI.E.4: Production of total ferrous iron and dialyzable ferrous iron by control, 
lyophilized raw and cooked (165oF and 195oF) chicken muscle samples. Graphical 
representation of the data from table 4. TFI: Total Ferrous Iron; DFI: Dialyzable 
ferrous Iron. 
 
Figure 4, shows that the total ferrous iron values obtained for digested lyophilized raw 
and cooked samples (165oF and 195oF) are distinct from control (p<0.05). The total 
ferrous iron values for chicken muscle samples are ~1.5 times higher than no protein 
control, which suggests that chicken muscle produced higher amounts of total ferrous 
iron as compared to no protein control. The total ferrous iron values for lyophilized 
raw and cooked samples (165oF and 195oF) are not distinctly different from each 
other when analyzed using one way ANOVA (p>0.05). This implies that the factor(s) 
responsible for producing total ferrous iron is not destroyed by cooking. The values 
for dialyzable ferrous iron for lyophilized raw and cooked (165oF) are distinct from 
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no protein control (p<0.05), but for cooked (195oF) it is not distinct from control 
(p>0.05). Lyophilized raw and cooked (165oF) sample produced ~2.5 times higher 
values for most potentially bioavailable form of iron i.e. dialyzable ferrous iron as 
compared to no-protein control. This suggests that the factor(s) responsible for 
producing the most potentially bioavailable form of iron and carry it through 6000-
8000 Da dialysis membrane was not destroyed after heating the chicken muscle 
sample at 165oF. The dialyzable ferrous iron value for cooked (195oF) was much 
lower than lyophilized raw and cooked (165oF) CMS, and slightly higher than no 
protein control but not significantly different. This implies that the factor(s) 
responsible for producing most potentially bioavailable form of iron is also heat labile 
and destroyed completely at 195oF. The major component suggested to produce 
ferrous iron in meat is sulfhydryl (Taylor et al. 1986; Kirwan et al. 1993; Mulvihill 
and Morrissey, 1998; Mulvihill et al. 1998) and it is well know that sulfhydryl is heat 
labile. So the drop in dialyzable ferrous iron could be attributed to the loss of 
sulfhydryls during heating the chicken muscle sample.  
 
Table 5 gives the values for total dialyzable iron for control, lyophilized raw and 
cooked (165oF and 195oF) samples for iron only, iron pepsin and iron pepsin 
pancreatin bile treatments. 
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Sample 
 
Iron Only  
(No Enzymes) 
Iron/Pep  
(No PB) 
 
Iron/Pep/PB 
 Mean ± SD 
Total Dialyzable Iron [Fe(II) + Fe (III)] µg 
Control 
(No Sample)) 
 
2.9 ± 0.44 a 
 
3.4 ± 0.52 a 
 
6.0 ± 0.70 c 
Raw 
Sample 
 
8.4 ± 0.49 b 
 
19.4 ± 0.45 d 
 
24.5 ± 1.73 f 
Cooked 165oF 
Sample 
 
6.0 ± 0.70 c 
 
14.6 ± 0.75 e 
 
21.7 ± 0.90 f 
Cooked 195oF 
Sample 
 
4.0± 0.95 a 
 
15.5 ± 0.79 e 
 
21.1 ± 1.27 f 
 
Table VI.E.5: Total dialyzable iron produced by control, lyophilized raw and cooked 
(165oF and 195oF) chicken muscle samples for Iron only (no enzymes), iron pepsin 
(no pancreatin) and iron/pep/PB treatments. Mean ± SD of total dialyzable [Fe (II) + 
Fe (III)] in µg for total 6 pancreatin digestions (n = 6). The total amount of iron used 
for each pancreatin digestion is 279 µg. Different subscripts indicates difference using 
One Way ANOVA test for α = 0.05 or 95% confidence. Endogenous iron produced 
by the same amount of sample has been subtracted from all the values. Pep: Pepsin; 
PB: Pancreatin Bile. 
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Figure VI.E.5: Production of total dialyzable iron by control, lyophilized raw and 
cooked (165oF and 195oF) chicken muscle samples for iron only (no enzymes), iron-
pep (no pancreatin) and iron pepsin pancreatin bile. Graphical representation of the 
data from table 5. 
 
 
Figure 5, indicates the effect of iron only (no enzymes), pepsin (no pancreatin) and 
pepsin-pancreatin/bile digestion by lyophilized raw and cooked (165oF and 195oF) 
CMS on production of total dialyzable iron and the values are significantly distinct 
from each other (p<0.05). The iron only (no enzymes) treatment values for total 
dialyzable iron produced by lyophilized raw and cooked (165oF and 195oF) chicken 
muscle samples are slightly higher than control, which suggests that chicken muscle 
does not need digestion to produce potentially bioavailable forms of iron. The values 
obtained for total dialyzable iron for lyophilized raw and cooked (165oF and 195oF) 
CMS show ~2.5 and ~3 times increase when pepsin (no pancreatin) and pepsin-
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pancreatin/bile were used for the digestion respectively, as compared with iron only 
(no enzymes). This shows that chicken muscle do not need digestion to enhance iron 
bioavailability but this also suggests that digestion further enhances production of 
potentially bioavailable forms of iron by ~3 times. This result is in contradiction with 
that obtained by Huh et al., which suggested that digestion is not necessary to produce 
potentially bioavailable forms of iron in heated lyophilized fish muscle (Huh et al. 
2005). 
 
Table 6 gives the values for dialyzable ferrous iron for lyophilized raw and cooked 
(165oF and 195oF) samples for iron only, iron pepsin and iron pepsin pancreatin bile 
treatments. 
110 
 
 
 
 
 
 
Sample 
 
Iron Only  
(No Enzymes) 
Iron/Pep  
(No PB) 
 
Iron/Pep/PB 
 Mean ± SD 
Dialyzable Ferrous Iron [Fe(II)] µg 
Control 
(No Sample)) 
 
2.0 ± 0.46 a 
 
1.8 ± 0.50 a 
 
2.8 ± 0.34 a 
Raw 
Sample 
 
3.8 ± 0.96 b 
 
8.4 ± 0.32 c 
 
7.4 ± 1.38 c 
Cooked 165oF 
Sample 
 
3.2 ± 0.42 b 
 
6.4 ± 1.08 c 
 
7.2 ± 0.55 c 
Cooked 195oF 
Sample 
 
2.6 ± 0.42 a 
 
3.2 ± 0.60 ab 
 
4.2 ± 1.50 ab 
 
Table VI.E.6: Dialyzable ferrous iron produced by control, lyophilized raw and 
cooked (165oF and 195oF) chicken muscle samples for Iron only (no enzymes), iron 
pepsin (no pancreatin) and iron/pep/PB. Mean ± SD of total dialyzable [Fe (II) + Fe 
(III)] in µg for total 6 pancreatin digestions (n = 6). The total amount of iron used for 
each pancreatin digestion is 279 µg. Different subscripts indicates difference using 
One Way ANOVA test for α = 0.05 or 95% confidence. Endogenous iron produced 
by the same amount of sample has been subtracted from all the values. Pep: Pepsin; 
PB: Pancreatin Bile. 
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Figure VI.E.6: Production of dialyzable ferrous iron by control, lyophilized raw and 
cooked (165oF and 195oF) chicken muscle samples for iron only (no enzymes), iron-
pep (no pancreatin) and iron pepsin pancreatin bile. Graphical representation of the 
data from table 6. 
 
 
The effect of iron only (no enzymes), pepsin (no pancreatin) and pepsin-
pancreatin/bile digestion treatments on production of dialyzable ferrous iron by 
lyophilized raw and cooked (165oF and 195oF) CMS is shown in figure 6. There was 
no difference on dialyzable ferrous iron produced by lyophilized raw and cooked 
165oF CMS for iron only treatment, but these values were ~1.5 times higher than 
control. There was no significant difference between control and lyophilized cooked 
195oF CMS, suggesting that the factor responsible for production of dialyzable 
ferrous iron for iron only treatment was destroyed completely at 195oF. The 
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dialyzable ferrous iron produced by raw chicken was five times higher than that of 
control for iron pepsin treatment but heating chicken to 165oF did not cause any drop. 
However when the chicken was heated to 195oF, a significant change was observed, 
suggesting that the factor(s) responsible for production of dialyzable ferrous iron was 
destroyed completely at 195oF, as the value is equal control. Also, these results 
indicated that digestion is not necessary for production of dialyzable ferrous iron but 
it helps to increase the amount of dialyzable ferrous iron significantly. 
 
Table 7 gives the values for total dialyzable iron and dialyzable ferrous iron produced 
because of digestion (non-digested iron values are subtracted from the digested iron 
values for the corresponding sample) by control, lyophilized raw and cooked (165oF 
and 195oF) chicken muscle samples. 
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Sample Total dialyzable iron in 
µg 
 
 
Dialyzable ferrous iron 
in µg 
 
 
Mean ± SD 
 
 
Control 
 
3.6 ± 0.93 a 
 
0.7 ± 0.34 c 
 
Raw Chicken 
 
16.0 ± 1.73 b 
 
3.6 ± 1.38 d 
 
Cooked (165oF) chicken 
 
15.6 ± 0.90 b 
 
3.9 ± 0.55 d 
 
Cooked (195oF) chicken 
 
17.1 ± 1.27 b 
 
1.6 ± 1.50 d 
 
Table VI.E.7: Total dialyzable iron and dialyzable ferrous iron produced because of 
digestion (digested iron – non-digested iron values) by control, lyophilized raw and 
cooked (165oF and 195oF) chicken muscle samples. Mean ± SD of total dialyzable [Fe 
(II) + Fe (III)] and dialyzable ferrous iron [Fe (II)] in µg for total 6 pancreatin 
digestions (n = 6). The total amount of iron used for each pancreatin digestion is 279 
µg. Different subscripts indicates difference using One Way ANOVA test for α = 0.05 
or 95% confidence. Endogenous iron produced by the same amount of sample has 
been subtracted from all the values. 
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Figure VI.E.7: Production of dialyzable ferrous iron by control, lyophilized raw and 
cooked (165oF and 195oF) chicken muscle samples for iron only (no enzymes), iron-
pep (no pancreatin) and iron pepsin pancreatin bile. Graphical representation of the 
data from table 7. 
 
 
The total dialyzable iron and dialyzable ferrous iron produced because of digestion 
(non-digested iron values are subtracted from digested iron values for the 
corresponding sample) is shown in fig 7. The total dialyzable iron produced because 
of digestion for raw and cooked chicken sample is ~5 times greater than that of 
control. Also, the dialyzable ferrous iron produced because of digestion for raw and 
cooked 165oF chicken sample is ~4 times higher than control, whereas for 195oF 
sample, it is two times as much as that of control.  
These results clearly showed that majority of total dialyzable iron are produced during 
digestion. So digestion is very critical for production of potentially bioavailable forms 
of iron. Also, it can be seen that, there is no effect of cooking on production of total 
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dialyzable iron. As far as the dialyzable ferrous iron is concerned, there is not 
significant difference for raw and cooked sample and heating does not have any effect 
on it.  
It can be concluded from these results that digestion is very necessary for production 
of potentially bioavailable forms of iron and heating does not have any effect on 
ability of chicken to produce potentially bioavailable forms of iron.  
 
Table 8 gives the values for total soluble protein and total dialyzable protein produced 
by lyophilized raw and cooked (165oF and 195oF) chicken muscle samples. 
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Sample Total soluble protein in 
mg 
Total dialyzable protein 
in mg 
 
 
 
Mean ± SD 
 
 
Raw Chicken 
 
320.5 ± 4.11 a 
 
223.4 ± 12.48 d 
 
Cooked (165oF) chicken 
 
362.6 ± 10.92 b 
 
260.7 ± 16.3 e 
 
Cooked (195oF) chicken 
 
385.4 ± 9.63 c 
 
293.4 ± 14.75 f 
 
Table VI.E.8: Total soluble protein and total dialyzable protein values for lyophilized 
raw and cooked (165oF and 195oF) chicken muscle samples. Mean ± SD of total 
soluble protein and total dialyzable protein in mg for total 6 pancreatin digestions (n = 
6). The total amount of protein used for each pancreatin digestion is 400 mg. Different 
subscripts indicates difference using One Way ANOVA test for α = 0.05 or 95% 
confidence.  
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Figure VI.E.8: Production of total soluble protein and total dialyzable protein because 
of digestion (digested iron – non-digested iron values) by control, lyophilized raw and 
cooked (165oF and 195oF) chicken muscle samples. Graphical representation of the 
data from table 8. TSP: Total Soluble Protein; TDP: Total Dialyzable Protein. 
 
 
Figure 8, indicates that the total soluble protein and total dialyzable protein values for 
lyophilized raw and cooked (165oF and 195oF) is significantly different from each 
other (p<0.05). This suggests that as the temperature of heating increases, the 
digestibility of protein improves, may be because of denaturation of proteins, which 
helps for better digestion. This also implies that the digestion process was adequate 
and is not the component of variation responsible for production of different amount 
of dialyzable and soluble iron. 
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VI.F. Conclusions: 
 
After this study, we came to following conclusions: 
 
 Sulfhydryl and histidines are very heat labile and drops significantly after 
cooking at 195oF 
 
 The total dialyzable iron was not affected after cooking the sample at 165oF, 
even though there was significant drop in sulfhydryl and histidine content. 
 
 Dialyzable ferrous iron dropped to the level which is not significantly different 
from control after heating the sample to 195oF, which is well correlated with 
the drop in total sulfhydryl content. 
 
 Chicken muscle does not need digestion to produce potentially bioavailable 
forms of iron, but digestion further enhances its production.  
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APPENDIX A:  
STANDARD CURVE FOR PROTEIN 
 
 
Abs at 542nm Obs. 
No. 
BSA (mg) 
I II 
Final Abs 
1 
 
0.0 0.053 0.052 0.00 
2 
 
1.0 0.107 0.104 0.052 
3 2.0 
 
0.162 0.164 0.110 
4 4.0 
 
0.268 0.268 0.216 
5 6.0 
 
0.370 0.370 0.318 
6 8.0 
 
0.475 0.474 0.422 
7 10.0 
 
0.560 0.560 0.508 
Table A.1: Observations for standard protein (BSA) sample. 
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Fig A.1. Protein standard graph. Standard curve using bovine serum albumin as a 
standard protein. 
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APPENDIX B:  
STANDARD CURVE FOR Fe 
 
 
Abs at 562nm Obs 
No. 
 
Fe Conc. (ug) 
I II III 
Final Abs. 
1 
 
0.0 0.037 0.032 0.037 0.000 
2 
 
1.0 0.205 0.206 0.203 0.168 
3 
 
2.0 0.365 0.368 0.395 0.328 
4 
 
3.0 0.544 0.547 0.546 0.504 
5 
 
4.0 0.700 0.707 0.692 0.670 
6 
 
5.0 0.853 0.830 0.860 0.823 
Table B.1: Observations for standard iron sample. 
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Fig B.1. Iron standard graph. Standard graph for iron using a standard iron solution. 
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2g protein 
Add DDW, adjust pH to 2.5 
Add 1.4 ml of iron, adjust weight to 95g 
Adjust pH to 2.0, and recheck after 15 min. 
Incubate at 37oC in a shaking water bath 
Add 5 ml of pepsin digest. Allow to digest for 2 hrs. 
Keep on ice to stop digestion 
Take a 20g aliquot 
for titratable acidity 
20g for pancreatin 
digestion 
Determine amount 
of NaHCO3 
Add dialysis tubing 
having 20ml of NaHCO3 
Incubate at 370C for 30 
mins, observe pH 
Add 5ml of pancreatin/BILES 
solution. Digest for 2 hrs. 
Weigh Dialyzate Weigh Non-dialyzate 
Total Iron Ferrous Iron Total Iron 
20g for pancreatin 
digestion 
20g for pancreatin 
digestion 
Ferrous Iron 
Protein Protein 
APPENDIX C.  
FLOW DIAGRAM FOR THE DIGESTION PROTOCOL 
 
  
 
 
 
 
 
 
 
              
            Pepsin Digestion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pancreatin Digestion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig C.1: Flow diagram for digestion protocol. 
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